Thermo Fisher Q3 Earnings Top Estimates, Revenues Miss, Stock Dips
- In the third quarter of 2024, TMO continued to advance its growth strategy and trusted partner status with customers.
- 10/23/2024
|
Thermo Fisher Scientific Q3: Expecting Market Recovery In FY25; Upgrade To 'Buy'
- I am upgrading Thermo Fisher Scientific Inc. to a “Buy” with a fair value of $610 per share due to anticipated recovery in the pharma and biotech industries. Thermo Fisher's high-impact innovations and strategic M&A, including the acquisition of Olink, support a 7%-9% organic revenue growth and mid-teens EPS growth. Q3 results show stabilization in life sciences, with raised full-year adjusted EPS guidance, maintaining revenue guidance of $42.4 to $43.3 billion.
- 10/23/2024
|
Thermo Fisher Scientific (TMO) Q3 Earnings Top Estimates
- Thermo Fisher Scientific (TMO) came out with quarterly earnings of $5.28 per share, beating the Zacks Consensus Estimate of $5.25 per share. This compares to earnings of $5.69 per share a year ago.
- 10/23/2024
|
Thermo Fisher raises profit forecast on strong demand for its tools and services
- Thermo Fisher Scientific on Wednesday raised the lower end of its annual profit forecast, tweaking it for the third time this year, betting on improved demand for its tools and services used in drug development.
- 10/23/2024
|
Thermo Fisher Scientific Reports Third Quarter 2024 Results
- WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the third quarter ended September 28, 2024. Third Quarter 2024 Highlights Third quarter revenue was $10.60 billion. Third quarter GAAP diluted earnings per share (EPS) was $4.25. Third quarter adjusted EPS was $5.28. Advanced our proven growth strategy, launching a range of high-impact, innovative new products during the quarter. To enable the.
- 10/23/2024
|
Will These 3 MedTech Stocks Surpass Q3 Earnings Forecasts?
- Here is a sneak peek into how three MedTech stocks, BSX, TMO and ALGN, are expected to fare in their third-quarter results, slated to be released tomorrow.
- 10/22/2024
|
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
- The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
- 10/22/2024
|
Lab Consumables Business Research Report 2024-2030 with Focus on 350+ Select Players Including Thermo Fisher Scientific, VITLAB, Bellco Glass, Eppendorf and BRAND Scientific Equipment Among Others
- Dublin, Oct. 22, 2024 (GLOBE NEWSWIRE) -- The "Lab Consumables - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Lab Consumables is estimated at US$12.7 Million in 2023 and is projected to reach US$17.2 Million by 2030, growing at a CAGR of 4.5% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
- 10/22/2024
|
Thermo Fisher (TMO) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
- Evaluate the expected performance of Thermo Fisher (TMO) for the quarter ended September 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
- 10/18/2024
|
Thermo Fisher Scientific (TMO) Expected to Beat Earnings Estimates: Should You Buy?
- Thermo Fisher (TMO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 10/16/2024
|
Robust Analytical Instrument Segment Likely to Aid TMO's Q3 Earnings
- Strength in Analytical Instrument and Specialty Diagnostics segments is likely to have driven Thermo Fisher's third-quarter 2024 performance.
- 10/14/2024
|
Thermo Fisher Scientific Introduces Fully Integrated Multimodal Analytical Scanning Transmission Electron Microscope to Advance Novel Research in Materials Science
- WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, introduced a groundbreaking transmission electron microscope to a packed room of attendees at the recent European Microscopy Congress 2024 in Copenhagen, Denmark. As a fully integrated multimodal analytical solution, the Thermo Scientific™ Iliad™ (Scanning) Transmission Electron Microscope, (S)TEM, gives scientific pioneers deeper insights about the chemical nature of the most sophisticated mode.
- 10/14/2024
|
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
- Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and deserve attention.
- 10/11/2024
|
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names
- The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
- 10/10/2024
|
TMO's New ICP-MS Systems Boost Trace Element Analysis: Stock to Gain?
- Thermo Fisher introduces the iCAP MX Series ICP-MS to simplify trace elemental analysis.
- 10/08/2024
|
Should You Continue to Hold TMO Stock in Your Portfolio?
- Thermo Fisher advances in its growth strategy, supported by its wave of innovations. However, macroeconomic issues escalate expenses.
- 10/07/2024
|
Thermo Fisher Scientific Showcases Expanded Biopharma Services, Capabilities and Innovations at CPHI Milan 2024
- MILAN--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, will showcase its latest innovations enabling the molecule-to-medicine journey and host a series of sessions that feature industry developments during CPHI Milan 2024, Oct. 8-10, in Milan, Italy. Leaders and experts from the company will be present at conference booth #7B18 to discuss how Thermo Fisher is supporting biotechnology and pharmaceutical companies across indications, modalities, sizes and stag.
- 10/07/2024
|
Thermo Fisher Scientific: Fantastic Company, Rich Valuation
- Thermo Fisher has outperformed the market with a 420%+ return over the past decade, but its current valuation is high. The company's recent results show mixed performance, with slight revenue decline, but improved earnings-per-share and raised 2024 guidance. Despite strong growth prospects and market tailwinds, the stock's high valuation and low dividend yield make it a hold for now.
- 10/04/2024
|
Exclusive: Thermo Fisher's plant making infant RSV drug breached FDA rules, documents show
- One of the largest contract drug manufacturing plants in the U.S. owned by Thermo Fisher Scientific over the past 10 years has repeatedly breached rules meant to ensure drugs are free of contamination, FDA documents show, including twice this year.
- 10/04/2024
|
Will Thermo Fisher (TMO) Beat Estimates Again in Its Next Earnings Report?
- Thermo Fisher (TMO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 10/03/2024
|
TMO Stock Likely to Gain From New International CorEvitas AD Registry
- Thermo Fisher launches international CorEvitas clinical registry in adolescent AD.
- 10/02/2024
|
Industry Leader Thermo Fisher's Contract Services Positioned For Growth Amid Popular Demand For GLP-1 Weight Loss Drugs, Analyst Initiates With Long-Term Growth Potential
- Stephens initiated coverage on Thermo Fisher Scientific TMO and cited the company as an industry leader in the broader life science tools/services/ diagnostics industry, with fiscal year 2023 sales of almost $42.9 billion.
- 10/01/2024
|
Calls of the Day: General Motors, GE Healthcare, Thermo Fisher, HealthEquity, Carmax and SharkNinja
- The Investment Committee debate the latest Calls Of The Day and Jim Lebenthal responds to Sarat Sethi selling out of General Motors
- 10/01/2024
|
TMO Stock Gains From Innovation Amid Macroeconomic Issues
- Thermo Fisher's business strategy involves expansion through strategic acquisition of technologies and businesses that boost its existing products and services.
- 10/01/2024
|
Thermo Fisher Scientific Introduces Mass Spectrometers to Simplify Trace Elemental Analysis and Enhance Productivity
- WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. today launched the Thermo Scientific™ iCAP™ MX Series ICP-MS to simplify trace element analysis with inductively coupled plasma mass spectrometry (ICP-MS). The launch includes a new single quadrupole Thermo Scientific iCAP MSX ICP-MS and triple quadrupole Thermo Scientific iCAP MTX ICP-MS designed for environmental, food, industrial and research labs to analyze routine and challenging trace elements to detect and mitigate harmful su.
- 10/01/2024
|
Thermo Fisher Scientific Launches International CorEvitas Clinical Registry in Adolescent Atopic Dermatitis, a Chronic Skin Condition
- WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of the international CorEvitas Adolescent Atopic Dermatitis (AD) Registry, designed to study novel treatments for the most common inflammatory skin condition in adolescent patients. The registry recently enrolled its first European Union patient, expanding its geographic footprint of enrollment beyond North America, where the first patient was enrolled in December 2023.
- 09/30/2024
|
Thermo Fisher Scientific Expands Oral Solid Dose Development and Manufacturing Capabilities Across North America
- CINCINNATI & BEND, Ore.--(BUSINESS WIRE)--To provide flexible and innovative solutions for early development challenges commonly faced by biotech and pharmaceutical companies, Thermo Fisher Scientific Inc. is expanding its oral solid dose (OSD) footprint with a $22-million total investment since 2021 in its Cincinnati, Ohio, and Bend, Ore. sites. Together, these expansions will enable research and development (R&D), manufacturing and testing of OSD drug formulations – doubling the Bend site.
- 09/26/2024
|
TMO Stock to Gain From Expanded Bioanalytical Services in Sweden
- Thermo Fisher's PPD arm unveils a new facility in Sweden, expanding its bioanalytical capabilities.
- 09/19/2024
|
Biognosys Enters Reselling Agreement for Spectronaut Proteomics Software with Leading Provider of Mass Spectrometry Systems
- Biognosys' Spectronaut®, the leading vendor-agnostic software for DIA proteomics, is now directly available from Thermo Fisher Scientific under a reselling agreement End users can get access to Thermo Scientific mass spectrometry systems and Biognosys' Spectronaut software via a single offer issued by Thermo Fisher Thermo Fisher will directly quote and sell Biognosys' Spectronaut software from its product catalog ZURICH and NEWTON, Mass., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Biognosys, a leading inventor and provider of software solutions for mass spectrometry-based proteomics data analysis, today announced the rollout of a Value-added Reselling agreement for Biognosys' Spectronaut® software with Thermo Fisher Scientific.
- 09/18/2024
|
Thermo Fisher Scientific (TMO) presents at Morgan Stanley 22nd Annual Global Healthcare Conference - Conference Call Transcript
- Thermo Fisher Scientific (NYSE:TMO ) Morgan Stanley 22nd Annual Global Healthcare Conference September 5, 2024 8:30 AM ET Company Participants Marc Casper - Chairman, President and CEO Conference Call Participants Tejas Savant - Morgan Stanley Tejas Savant Hey, everyone. Good morning.
- 09/05/2024
|
Why Is Thermo Fisher (TMO) Up 1.6% Since Last Earnings Report?
- Thermo Fisher (TMO) reported earnings 30 days ago. What's next for the stock?
- 08/23/2024
|
Reasons to Retain Thermo Fisher (TMO) in Your Portfolio Now
- Strategic alliances and impressive product launches bode well for Thermo Fisher (TMO).
- 08/21/2024
|
Thermo Fisher Scientific Innovations Achieve R&D 100 Awards, including Special Recognition Market Disruptor
- WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, has received three R&D 100 Awards for innovations that aid researchers' and scientists' work in a variety of life science applications, including proteomics, bioproduction and small-molecule analysis. Notably, the Thermo Scientific™ Orbitrap™ Astral™ Mass Spectrometer (MS) won gold in the Market Disruptor special recognition category as one of the most significant advancements in mass spectr.
- 08/15/2024
|
Thermo Fisher's (TMO) CDx Gets FDA's Nod for Synovial Sarcoma
- Thermo Fisher Scientific TMO recently secured FDA's 510(k) clearance for its SeCore CDx HLA A Sequencing System for use as a companion diagnostic (CDx) alongside Adaptimmune's ADAP newly approved T-cell receptor (TCR) therapy, TECELRA (afamitresgene autoleucel). The latter is the first engineered cell therapy for a solid tumor cancer approved in the United States and the first new therapy option in more than a decade for synovial sarcoma — a rare, soft tissue cancer that most commonly impacts young adults.
- 08/13/2024
|
Healthy Profits: 7 Healthcare Stocks to Build a Lifetime of Wealth
- There are a whole host of reasons to invest in healthcare stocks over the long term. The United States has an aging population.
- 07/30/2024
|
3 Stocks With the Most Recent 52-Week Highs
- The overall stock market has been reeling over the last week or so. The S&P 500 index and NASDAQ have fallen by 4% and 6%, respectively, since July 16 due to uncertainty regarding the future of artificial intelligence.
- 07/29/2024
|
Thermo Fisher: A Dividend Investor's Lab Partner For Growth And Stability
- Thermo Fisher Scientific is a top dividend growth stock with a complex post-pandemic situation. Recent earnings show promising growth in key segments, despite a high valuation. Strategic investments in R&D and acquisitions position TMO for continued long-term success.
- 07/28/2024
|
3 Nanotechnology Stocks With Microscopic Risk
- Given the expanding size of the nanotechnology industry, buying nanotechnology stocks with a very low-risk profile is possible. Electronics is one of the most important sectors that applies nanotechnology.
- 07/25/2024
|
Thermo Fisher Scientific: Microscopic Signs Of Growth Emerging
- Thermo Fisher Scientific is finally starting to show signs of growth after getting through the headwind of declining covid-related business. Growth sources include increased business in China, completion of the Olink deal, and an increase in the number of clinical trials. Financial model updates and valuation analysis suggest the stock is currently priced at fair value, making it a Hold for now.
- 07/25/2024
|
Thermo Fisher (TMO) Beats on Q2 Earnings, Raises 2024 EPS View
- The year-over-year decline in Thermo Fisher's (TMO) Life Science Solutions and Laboratory Products and Biopharma Services revenues disappoints. However, margins expand in the second quarter.
- 07/24/2024
|
Thermo Fisher (TMO) Reports Q2 Earnings: What Key Metrics Have to Say
- The headline numbers for Thermo Fisher (TMO) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
- 07/24/2024
|
Thermo Fisher Q2 Earnings Beat Estimates, Guidance Lifted
- Thermo Fisher Scientific (TMO) reported better second-quarter earnings than analysts had expected Wednesday, and also raised its projections for the full fiscal year.
- 07/24/2024
|
Thermo Fisher Scientific (TMO) Q2 Earnings and Revenues Top Estimates
- Thermo Fisher Scientific (TMO) came out with quarterly earnings of $5.37 per share, beating the Zacks Consensus Estimate of $5.13 per share. This compares to earnings of $5.15 per share a year ago.
- 07/24/2024
|
Thermo Fisher lifts profit forecast as biotech demand shows signs of improvement
- Thermo Fisher on Wednesday raised its annual profit outlook and posted a better-than-expected second-quarter profit, banking on improved demand for its tools and services used in clinical trials.
- 07/24/2024
|
Can These 4 MedTech Stocks Hit Targets This Earnings Season?
- Here is a sneak peek into how four MedTech bigshots, BSX, TMO, ALGN and EW, are expected to fare in their second-quarter results, slated to be released tomorrow.
- 07/23/2024
|
3 Nantotech Stocks to Bet On for Market-Crushing Returns
- Nanotech stocks remain at the forefront of every tech-savvy investor's portfolio, considering the predicted worldwide nanotechnology market size in 2024 is $91.18 billion. Analysts project market size will reach $332.73 billion by 2032, with a CAGR of 17.6%.
- 07/23/2024
|
$7.1 Billion Medical Refrigerators Market and Industry Insights, 2024-2030, Featuring Strategic Analysis of 42 Major Players, Including Godrej, Haier Biomedical, Thermo Fisher Scientific
- Dublin, July 18, 2024 (GLOBE NEWSWIRE) -- The "Medical Refrigerators - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Medical Refrigerators is estimated at US$4.4 Billion in 2023 and is projected to reach US$7.1 Billion by 2030, growing at a CAGR of 6.9% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. Key Insights:
- 07/18/2024
|
Analysts Estimate Thermo Fisher Scientific (TMO) to Report a Decline in Earnings: What to Look Out for
- Thermo Fisher (TMO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 07/17/2024
|
Here's How Thermo Fisher (TMO) is Placed Ahead of Q2 Earnings
- Strength in Analytical Instrument and Laboratory Products and Services segments is likely to have driven Thermo Fisher's (TMO) second-quarter 2024 performance.
- 07/17/2024
|
The Zacks Analyst Blog DexCom, Hologic, Alcon Intuitive Surgical and Thermo Fisher Scientific
- DexCom, Hologic, Alcon Intuitive Surgical and Thermo Fisher Scientific are included in this Analyst Blog.
- 07/16/2024
|
Stock Of The Day: How To Predict Thermo Fisher Scientific Trend Reversals
- Stocks tend to sell off after they reach resistance. They also tend to rally off of support.
- 07/15/2024
|
Buy 5 Medical Devices Stocks to Enhance Your Portfolio in 2H
- We have narrowed our search to five Medical Instruments stocks. These are: DXCM, TMO, ISRG, ALC, HOLX.
- 07/15/2024
|
Thermo Fisher (TMO) Inks New Partnership for myeloMATCH Trial
- Thermo Fisher (TMO) announces a partnership with the National Cancer Institute for the myeloMATCH precision medicine umbrella trial to fuel research regarding new treatments for AML and MDS.
- 07/12/2024
|
Thermo Fisher Scientific Declares Quarterly Dividend
- WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0.39 per common share, payable on October 15, 2024, to shareholders of record as of September 13, 2024. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world h.
- 07/11/2024
|
TMO or IDXX: Which Is the Better Value Stock Right Now?
- Investors with an interest in Medical - Instruments stocks have likely encountered both Thermo Fisher Scientific (TMO) and Idexx Laboratories (IDXX). But which of these two stocks is more attractive to value investors?
- 07/11/2024
|
Thermo Fisher (TMO) to Open New NanoPort Facility in Taiwan
- Thermo Fisher (TMO) announces the opening of NanoPort, the company???s first electron microscopy demo center in Taiwan, strategically located in the region?
- 07/10/2024
|
Thermo Fisher (TMO) Strategic Buyouts Aid Amid Macro Issues
- Thermo Fisher's (TMO) business strategy primarily includes expansion through strategic acquisition of technologies and businesses that augment the company's existing products and services.
- 07/09/2024
|
UK's competition regulator clears $3.1 bln Thermo Fisher Scientific-Olink deal
- UK's competition regulator said on Monday it has cleared U.S. medical equipment maker Thermo Fisher Scientific's $3.1 billion deal to buy Swedish biotech firm Olink Holding AB.
- 07/08/2024
|
3 Biotech Stocks Turning DNA Dreams Into Dollars
- When discussing biotechnology, many focus on medication based on biochemical compounds and their downstream effects. Yet several branches of medical genetics and therapeutics have begun to find novel ways to treat and prevent diseases through gene editing, protein manipulation and overall DNA repair.
- 07/05/2024
|
3 Nanotech Stocks That Could Make Your Grandchildren Rich
- Advancements in semiconductor manufacturing, medical applications and materials science are projected to expand the nanotech market significantly in 2024. This backdrop forms the backdrop for my three nanotech stocks to buy.
- 07/03/2024
|
Thermo Fisher (TMO) Brings Biobased, Sustainable Films for BPCs
- Thermo Fisher (TMO) has launched biobased solutions to help reduce the climate impact on the manufacturing of therapies.
- 07/03/2024
|
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, July 24, 2024
- WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the second quarter 2024 before the market opens on Wednesday, July 24, 2024, and will hold a conference call on the same day at 8:30 a.m. EDT. During the call, the company will discuss its financial performance, as well as future expectations. To listen, call (833) 470-1428 within the U.S. or (404) 975-4839 outside the U.S. The.
- 07/02/2024
|
Thermo Fisher (TMO) Expands Central Lab Footprint in Kentucky
- Thermo Fisher (TMO) announces expansion of its central laboratory operations in Kentucky. The new space in Covington will be in addition to its existing central lab in Highland Heights.
- 07/02/2024
|
Thermo Fisher Scientific Expands Clinical Research Laboratory in Kentucky
- WILMINGTON, N.C.--(BUSINESS WIRE)--The PPD clinical research business announced the expansion of its central laboratory operations in Kentucky.
- 06/27/2024
|
Thermo Fisher's (TMO) New Launch Speeds Up pDNA Purification
- Thermo Fisher (TMO) introduces the Thermo Scientific KingFisher PlasmidPro, the fully automated maxi-scale pDNA purification system.
- 06/27/2024
|
You've Been Warned! 3 Nanotech Stocks to Buy Now or Regret Forever
- Nanotech stocks are among the hottest plays in the market right now, thanks to analysts predicting astronomical growth for the market. For example, Fortune Business Insights forecasted the market would grow to $91.18 billion in 2024 and reach $332.73 billion by 2032.
- 06/25/2024
|
Thermo Fisher Scientific Introduces the Only Fully Automated Plasmid Purification System to Help Accelerate Discovery and Development of Therapies
- WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the Thermo Scientific™ KingFisher™ PlasmidPro Maxi Processor* (PlasmidPro), the only fully automated maxi-scale plasmid DNA (pDNA) purification system. PlasmidPro enables innovation at scale, providing complete automation across mini and maxi scale purification and delivering high-purity plasmid without manual column preparation and intervention. This is the latest addition to t.
- 06/25/2024
|
Tecan appoints Mukta Acharya Head of the Life Sciences Business division
- Tecan appoints Mukta Acharya Head of the Life Sciences Business division Männedorf, Switzerland, June 24, 2024 – The Tecan Group (SIX Swiss Exchange: TECN) announced today that Mukta Acharya, currently serving as President, Tecan Americas, has been appointed the new Head of the Life Sciences Business division and a member of the Management Board of the Tecan Group. She is expected to assume her new position on August 1, 2024.
- 06/24/2024
|
Thermo Fisher (TMO) Unveils New Research Laboratory in WI
- Thermo Fisher Scientific Inc. TMO has announced a new clinical research laboratory building at its good manufacturing practices (GMP) lab in Middleton, WI, under its PPD clinical research business.
- 06/20/2024
|
Thermo Fisher's (TMO) New Buyouts Aid Growth, FX Issues Stay
- Thermo Fisher's (TMO) business strategy primarily includes expansion through strategic acquisition of technologies and businesses that augment the company's existing products and services.
- 06/20/2024
|
Thermo Fisher Scientific Extends the Expiration of Tender Offer for All Outstanding Common Shares and ADSs of Olink
- WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, announced that its wholly owned subsidiary, Orion Acquisition AB (the “Buyer”), has extended the expiration time of the offering period of its previously announced tender offer (the “Offer”) to acquire all of the outstanding common shares (“Shares”) and all of the outstanding American Depositary Shares, each representing one Share (“ADSs”), of Olink Holding AB (publ.
- 06/20/2024
|
Thermo Fisher Scientific Expands Clinical Research Laboratory in Wisconsin
- WILMINGTON, N.C.--(BUSINESS WIRE)--The PPD clinical research business of Thermo Fisher Scientific unveiled a new clinical research laboratory building in Middleton, Wisconsin.
- 06/18/2024
|
Nalgene Outdoor Celebrates 75 Years with Two Exclusive Designs
- ROCHESTER, N.Y.--(BUSINESS WIRE)--Get ready to raise your bottles high as Nalgene Outdoor, the “OG'' of reusable water bottles since ‘49, hits the big 7-5! Marking this milestone, Nalgene Outdoor is dropping not one, but two limited-edition, anniversary designs. One pays homage to Nalgene Outdoor's iconic “time-tested and adventure-approved” design, while the other reintroduces the brand's very first logo of a prowling Mountain Lion, a blast from the past reminding you why Nalgene bottles have.
- 06/17/2024
|
Thermo Fisher Scientific Showcases Clinical Research Innovation at DIA Annual Meeting
- SAN DIEGO--(BUSINESS WIRE)--The PPD clinical research business of Thermo Fisher Scientific is embracing DIA's theme of “Charting New Horizons” for its 60th annual meeting.
- 06/17/2024
|
A.I. Impact On Biopharma: LLY, AMGN, TMO, CRL
- The use of artificial intelligence across biopharma and life science tools and services is developing quickly. Will A.I. become a major disruptive technology in healthcare with the potential to significantly enhance productivity, reduce time spent in drug discovery, and optimize manufacturing processes?
- 06/14/2024
|
Thermo Fisher's (TMO) New Launch Supports Full Lab Automation
- Thermo Fisher's (TMO) first-of-its-kind innovation for CO2 incubators supports emerging automated cell therapy production processes.
- 06/14/2024
|
New Thermo Scientific Heracell Incubators Support the Future of Fully Automated Labs
- WALTHAM, Mass.--(BUSINESS WIRE)--To support the future implementation of workflow automation in cell therapy production, Thermo Fisher Scientific introduces the Thermo Scientific™ Heracell™ VIOS™ 250i AxD CO2 Incubators. These first-of-their-kind CO2 incubators are designed for integration into automated and modular laboratories. The VIOS family of incubators are known for optimal cell growth conditions and minimal contamination risk. Now adding the innovation of patent-pending automated door c.
- 06/12/2024
|
Top 4 Fastest Growing S&P 500 Dividends: Buy, Sell, or Hold?
- Dividends are a leading reason to buy a stock because the stock pays you to own it. Growing dividend distributions are more valuable than those that aren't; by extension, distributions growing faster than average are even more valuable.
- 06/12/2024
|
Thermo Fisher Scientific (TMO): 2024 Product Pipeline Analysis, Ongoing Clinical Trials Insights, and Developments, Including New CXCL10 Testing Service
- Dublin, June 10, 2024 (GLOBE NEWSWIRE) -- The "Thermo Fisher Scientific Inc (TMO) - Product Pipeline Analysis, 2024 Update" company profile has been added to ResearchAndMarkets.com's offering. This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. Report Scope:
- 06/10/2024
|
Here's Why Thermo Fisher (TMO) Should be in Your Portfolio
- Strategic alliances and impressive product launches bode well for Thermo Fisher (TMO).
- 06/07/2024
|
Low Yield, High Growth: Unveiling The Power Of Thermo Fisher's Dividends
- Thermo Fisher Scientific is well-positioned to benefit from the demand for innovation in the healthcare and biotech sectors. The company's strategic acquisitions have improved its growth capabilities and deepened its relationships with biopharma partners. Despite a low dividend yield, TMO has a history of strong total returns and consistent dividend growth, making it a compelling long-term investment.
- 06/07/2024
|
Nalgene Outdoor Named EF Go Ahead Tours' Official Water Bottle for Sustainable Travel
- ROCHESTER, N.Y.--(BUSINESS WIRE)--In advance of the busy summer travel season when an estimated 82% of Americans are planning to travel, EF Go Ahead Tours, a leading provider of guided group tours, proudly names Nalgene Outdoor, the original manufacturer of reusable water bottles as its official sustainable water bottle provider. This reflects a shared commitment to environmental responsibility in reducing single-use plastics in all of life's travel adventures, from the everyday to the once-in-.
- 06/04/2024
|
Thermo Fisher Scientific Unveils New Solutions Supporting Research Workflows at ASMS 2024
- ANAHEIM, Calif.--(BUSINESS WIRE)--To help accelerate the promise of precision medicine, Thermo Fisher Scientific today unveiled its new solutions accelerating research workflows at the annual American Society for Mass Spectrometry (ASMS) Conference on Mass Spectrometry and Allied Topics, in Anaheim, California. The new mass spectrometry and chromatography instruments and software solutions enable customers to unlock deeper analytical insights with built-for-purpose flexibility, improving produc.
- 06/03/2024
|
Thermo Fisher Scientific Introduces Innovative Mass Spectrometer to Advance Clinical Research
- ANAHEIM, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today unveiled the Thermo Scientific™ Stellar™ mass spectrometer (MS), a new solution that combines fast throughput, high sensitivity, and ease of use to allow researchers to advance their translational omics research and make breakthrough discoveries more efficiently. The Stellar MS powers translational research, the conversion of basic science discoveries into clinical application.
- 06/03/2024
|
Thermo Fisher Scientific Opens New GMP-certified Ultra-cold Facility in the EU to Accelerate Advanced Therapies Development
- BLEISWIJK, Netherlands--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, has opened a new clinical and commercial ultra-cold facility in the EU, expanding its clinical trial network in Europe to help accelerate the development of advanced therapies. The new current good manufacturing practice (cGMP) facility in Bleiswijk, Netherlands provides pharma and biopharma customers tailored, end-to-end support throughout the clinical supply chain for high-value therap.
- 06/03/2024
|
Thermo Fisher Scientific Updates Chromosomal Microarray Analysis Solutions to Comply with IVDR Regulation
- CARLSBAD, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, announced today that the Applied Biosystems™ CytoScan™ Dx Assay and Applied Biosystems™ Chromosomal Analysis Suite (ChAS) Dx software now comply with In Vitro Diagnostic Regulations (IVDR) 2017/746 in the European Union. These compliance updates will enable cytogenetics testing laboratories to adapt to the latest medical device safety and efficacy frameworks and conformity assessments. “Thermo.
- 05/31/2024
|
Thermo Fisher Scientific Releases 2023 Corporate Social Responsibility Report
- WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today released its 2023 Corporate Social Responsibility (CSR) report, which provides an overview of the company, its CSR priorities and the progress enabled by its more than 120,000 colleagues. “Thermo Fisher is driven by a profound Mission – to enable our customers to make the world healthier, cleaner, and safer,” said Marc N. Casper, chairman, president and chief executive officer.
- 05/28/2024
|
Thermo Fisher (TMO) Up 2.3% Since Last Earnings Report: Can It Continue?
- Thermo Fisher (TMO) reported earnings 30 days ago. What's next for the stock?
- 05/24/2024
|
Lab Instrument Industry Update - New Commercial Entrants
- Lab Instrument and Services providers in the healthcare industry can generate high recurring revenues. Many loss-making instrument makers in the industry may not provide meaningful returns and carry high risks. Cytek stands out as the best opportunity in the sector due to strong growth and manageable losses.
- 05/23/2024
|
Trilogy Metals Announces Election of Directors and Voting Results from the 2024 Annual Meeting of Shareholders
- VANCOUVER, BC , May 23, 2024 /PRNewswire/ - Trilogy Metals Inc. (TSX: TMO) (NYSE American: TMQ) ("Trilogy Metals" or the "Company") is pleased to announce the detailed voting results on the items of business considered at its Annual Meeting of Shareholders ("Meeting") held in Vancouver on Wednesday, May 22, 2024. All proposals were approved and the nominees listed in the management proxy circular for the meeting were all elected as directors.
- 05/23/2024
|
Thermo Fisher Scientific Declares Quarterly Dividend
- WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0.39 per common share, payable on July 15, 2024, to shareholders of record as of June 14, 2024. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier.
- 05/22/2024
|
3 Biotech Stocks to Buy Now: May 2024
- While it tends to fly under the radar for many people, the biotech industry has seen a resurgence in investor interest over the last couple of years. While there could be several reasons for this, such as the COVID-19 pandemic bringing the value of biotechnology to the forefront or even the expansion of education in the biosciences, the fact remains – biotech is getting more attention than ever before.
- 05/22/2024
|
Life Science Equipment Market to be Worth $97.96 Billion by 2031 - Exclusive Report by Meticulous Research®
- REDDING, Calif., May 20, 2024 /PRNewswire/ -- According to a new market research report titled, 'Life Science Equipment Market Size, Share, Forecast, & Trends Analysis By Technology (Spectroscopy, Microscopy, Chromatography (HPLC, GC, TLC), PCR, Immunoassay, Sequencing, Flow Cytometry, Microarray, Centrifuge) End User – Global Forecast to 2031,' published by Meticulous Research®, the life science equipment market is projected to reach $97.96 billion by 2031, at a CAGR of 6.3% from 2024 to 2031. Download Sample Report Now- https://www.meticulousresearch.com/download-sample-report/cp_id=3937 Life sciences encompass a wide range of fields, including biology, biochemistry, genetics, pharmacology, and many more. Laboratory equipment plays a critical role in conducting experiments, collecting data, and analyzing samples to further scientific research and advance our understanding of living organisms and their underlying mechanisms. Equipment is also necessary for quality checks and validation of manufactured drugs and biologics in the life sciences industry. The growth of the life sciences industry is driving the adoption of life sciences and laboratory equipment. The growth of this market is attributed to several factors, including increasing pharmaceutical and biotech R&D expenditures, government initiatives supporting life sciences R&D, the increasing prevalence of chronic and infectious diseases, and growth in initiatives to control environmental pollution. Additionally, the growth in genomics and proteomics, the increasing awareness and growing adoption of personalized medicines, increasing automation and digitalization in the life sciences industry, and the increasing focus on food safety and quality are expected to provide significant opportunities for players operating in the market. The report offers a competitive landscape based on an extensive assessment of the leading players' product portfolios and geographic presence and the key growth strategies adopted by them in the last three to four years. In recent years, the life science equipment market witnessed several product launches, product enhancements, product approvals, partnerships, agreements, & collaborations, acquisitions, and expansions. The key players operating in the life science equipment market are Agilent Technologies, Inc. (U.S.), Becton, Dickinson, and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), F. Hoffmann LA-Roche AG (Switzerland), PerkinElmer, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Waters Corporation (U.S.), Bruker Corporation (U.S.), Shimadzu Corporation (Japan), Siemens Healthineers AG (Germany), Eppendorf SE (Germany), Sartorius AG (Germany), and QIAGEN N.V. (Netherlands). Get a Glimpse Inside: Request Sample Pages- https://www.meticulousresearch.com/request-sample-report/cp_id=3937 Growing Awareness and Adoption of Personalized Medicine to Offer Opportunities for Players Operating in the Life Science Equipment Market Personalized medicine, also known as precision medicine, is an emerging approach to patient care. Physicians choose a treatment method based on the patient's genetic makeup (also considering genetic changes resulting from a disease) and lifestyle habits. It is an emerging disease treatment and prevention approach that considers individual variability in genes, environment, and lifestyle. Precision medicine can remove the need for guesswork, variable diagnostic ability, and treatment strategies based on generalized demographics. Moreover, precision medicine enables a more holistic view of an individual patient. Precision medicine for clinical workflows helps facilitate more predictive and preventive care by bringing targeted therapies. There has been an increase in the adoption of personalized medicine in recent years. For instance, according to the Personalized Medicine Coalition, the share of personalized medicine has increased steadily in the total drugs approved in the U.S. by the FDA, from 28% in 2015 to 35% in 2021. The increasing awareness and adoption of personalized medicine are driving the demand for specialized laboratory equipment and technologies that enable precise and accurate genetic and molecular analysis. Personalized medicine heavily relies on genetic testing, sequencing, analysis of genetic, genomic, and proteomic information, and biomarker identification and validation. This necessitates the use of advanced laboratory equipment, such as DNA sequencers, gene sequencers, PCR machines, real-time PCR systems, next-generation sequencers, mass spectrometers, immunoassay analyzers, and chromatography systems, to accurately derive the necessary results. The life science equipment market is segmented by Technology [Spectroscopy, Microscopy, Chromatography, Lab Automation, Immunoassay Analyzers, PCR, Sequencing, Flow Cytometry, Incubators, Microarray, Centrifuges, Electrophoresis, and Other Equipment], End User [Pharmaceutical and Biotechnology Industry, Academic & Research Institutes, Hospitals and Diagnostic Laboratories, Analytical Testing Laboratories, Agriculture and Food Industry, Forensic Laboratories, and Other End Users), and Geography. The study also evaluates industry competitors and analyzes the regional and country-level markets. (Note: Apart from primary segmentation, Spectroscopy, Microscopy, Chromatography, Lab Automation, Immunoassay Analyzer, PCR, Sequencing, Flow Cytometry, Microarray, Centrifuges, and Electrophoresis have further level segmentation). Have Specific Research Needs? Request a Customized Report-https://www.meticulousresearch.com/request-customization/cp_id=3937 Among the technologies included in the report, in 2024, the spectroscopy segment is expected to account for the largest share of 22% of the life science equipment market. The spectroscopy segment is further sub-segmented into molecular spectroscopy, atomic spectroscopy, mass spectrometry, and software. In 2024, the molecular spectroscopy segment is expected to account for the largest share of the spectroscopy market. Molecular spectroscopy is used to determine the composition of a material in an unknown chemical composition. It is used in various applications across food & beverage, environmental screening, pharmaceutical, and biotech industries. Therefore, the wide range of applications of molecular spectroscopy coupled with the growth of the life sciences industry, especially the pharmaceutical and biotech sectors, contribute to the large market share of this segment. Among the end users included in the report, in 2024, the pharmaceutical and biotechnology industry segment is expected to account for the largest share of 32% of the life science equipment market. The largest share is contributed by several factors, including the increased demand for new drugs and therapies leading to extensive research and development activities, the need for technologically advanced equipment in the pharmaceutical and biotech industries, the rise in funding and investments in the pharmaceutical and biotech industry, and increased healthcare expenditure. Among the geographies included in the report, in 2024, North America is expected to account for the largest share of 41% of the life science equipment market. North America's major market share is attributed to the presence of key players, its well-established life science industry, and substantial spending on R&D activities by pharmaceutical and biotech companies. The U.S. is home to global top-ranking pharmaceutical companies. Companies like Johnson & Johnson, Pfizer, AbbVie Inc., Merck, and Bristol Myers Squibb are headquartered in the U.S. These companies have high R&D expenditure at increasing at a high rate each year. For example, Johnson & Johnson spent USD 14.7 billion on research and development in 2021, with a 21% increase over 2020. Brows In-depth Report- https://www.meticulousresearch.com/product/life-science-equipment-market-3937 Scope of the Report: Life Science Equipment Market Assessment—by Technology Note: Other molecular spectroscopy technologies segment includes Raman spectroscopy, ellipsometry, and color measurement Note: Other atomic spectroscopy technologies segment includes inductively coupled plasma (ICP) spectroscopy, glow discharge spectroscopy, and arc/spark optical emission spectroscopy Note: Other microarrays segment includes glycan microarray, carbohydrate microarray, and chemical compounds microarrays Note: Other equipment segment includes autoclaves, stirrers & shakers, mixers, baths, hot plates, ovens & furnaces, and balances Life Science Equipment Market Assessment —by End User Note: Other end users include blood banks and industries, such as cosmetics, chemicals, oil & gas, electronics & semiconductors, automotive, aerospace, ceramics, plastics, rubber, and paints & coatings Life Science Equipment Market Assessment —by Geography Unlock Opportunities: Buy Now- https://www.meticulousresearch.com/Checkout/26911858 Related Reports: Genomics Market by Offering (Systems, Consumables, Software, Services), Technology (Sequencing, Microarray, PCR), Application (Diagnostics, Life Science Research), End User (Pharmaceutical Companies, Hospitals, Academic Institutes, CRO) - Global Forecast to 2030 NGS Automation Market by Product (Platform, Consumables), Sequencing Type (Whole Genome, Exome, Targeted), Application (Drug Discovery, Diagnostics), End User (Hospitals, Diagnostic Laboratories, Pharmaceutical, Academic) - Global Forecast to 2029 Liquid Handling Systems Market by Type (Automated, Electronic, Manual), Product (Pipette, Consumables, Burette, Software, Microplate), Application (Drug Discovery, Cancer & Genomics, Clinical), End User (Hospital, Diagnostic Lab) - Global Forecast to 2029 High-Performance Liquid Chromatography (HPLC) Market by Product (Instruments [Systems, Detectors], Consumables [Columns, Tubes], Accessories, Software), Application (Forensics, Diagnostics), End User (Research, Pharmaceuticals) - Global Forecast to 2030 Next Generation Sequencing Market by Type (Consumables, NGS Platform, Software), Sequencing Type (Whole Genome, Targeted), Technology (Sequencing by Synthesis, Sequencing by Ligation), Application (Clinical, Research), End User - Global Forecasts to 2030 Chromatography Reagents Market by Type (GC, LC, TLC), Product (Solvents, Buffers, Reagents), Separation (Adsorption, Partition, Affinity), Application (Pharma, Forensic, Environmental, Cosmeceuticals, Diagnostics, QC), End User - Global Forecast to 2030 Related Blogs: Top 10 Companies in Life Science Equipment Market Life Science Equipment: The Role of Various Technologies About Meticulous Research® Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth. Contact:Mr. Khushal BombeMeticulous Market Research Inc.1267 Willis St, Ste 200 Redding,California, 96001, U.S.USA: +1-646-781-8004Europe: +44-203-868-8738APAC: +91 744-7780008Email- [email protected] Visit Our Website: https://www.meticulousresearch.com/Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-researchContent Source: https://www.meticulousresearch.com/pressrelease/348/life-science-equipment-market-2031 Logo: https://mma.prnewswire.com/media/1757980/Meticulous_Research_Logo_1.jpg
- 05/20/2024
|
Thermo Fisher (TMO) Unveils New Extended Blood Genotyping Array
- Thermo Fisher's (TMO) new Applied Biosystems Axiom BloodGenomiX Array and Software provide a high-throughput solution for more precise blood matching research.
- 05/16/2024
|
Thermo Fisher Scientific Introduces Array-based Solution for Extended Blood Type Research to Support Future Advancements Toward Safer Transfusions
- WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the Applied Biosystems™ Axiom™ BloodGenomiX™ Array* and Software, a first-of-its-kind solution for more precise blood genotyping in clinical research. The new array detects most extended and rare blood groups, tissue (HLA) and platelet (HPA) types in a single, high-throughput assay, supporting future advancements in donor blood matching for extended phenotypes. Blood typing is a.
- 05/15/2024
|
Thermo Fisher Scientific Inc. (TMO) Presents at Bank of Bank of America Securities 2024 Health Care Conference (Transcript)
- Thermo Fisher Scientific Inc. (NYSE:TMO ) Bank of America Securities 2024 Health Care Conference Call May 14, 2024 11:00 AM ET Company Participants Marc Casper - Chairman, President & Chief Executive Officer Conference Call Participants Mike Ryskin - Bank of America Mike Ryskin Thanks everyone for joining us. For those of you who don't know me, my name is Mike Ryskin on BofA life science tools and diagnostics team.
- 05/14/2024
|
UK's CMA kicks off probe into Thermo Fisher-Olink deal
- Britain's competition regulator said on Friday it has initiated a probe into U.S. medical equipment maker Thermo Fisher Scientific's $3.1 billion deal to buy Swedish biotech firm Olink Holding AB.
- 05/10/2024
|
7 Robotics Stocks to Bet On for Reliable AI-Powered Returns
- Investors seeking reliable AI-powered returns should consider robotics stocks. Many companies are leveraging artificial intelligence to create human-like robots.
- 05/09/2024
|
Thermo Fisher Scientific to Present at BofA Securities 2024 Health Care Conference on May 14
- WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present at the BofA Securities Health Care Conference on Tuesday, May 14, 2024 at 11:00 a.m. (ET). The live webcast of the presentation can be accessed via the Investors section of our website, www.thermofisher.com. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in s.
- 05/07/2024
|
Don't Overlook Thermo Fisher (TMO) International Revenue Trends While Assessing the Stock
- Review Thermo Fisher's (TMO) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.
- 05/06/2024
|
Thermo Fisher Scientific Launches New CXCL10 Testing Service
- WEST HILLS, Calif.--(BUSINESS WIRE)--For organ transplant recipients, life post-transplant involves a delicate balance between invasive monitoring and immunosuppression to reduce the risk of rejection, both of which may carry complications. Now, a simple, urine-based assay that detects the CXCL10 chemokine may make care more convenient and less invasive for the nearly 250,000 Americans living with a kidney transplant. Thermo Fisher Scientific One Lambda Laboratories, a CLIA facility in Fishers,.
- 05/02/2024
|
Thermo Fisher (TMO) Q1 Earnings Top Estimates, 2024 View Up
- Thermo Fisher's (TMO) first-quarter 2024 revenues register year-over-year growth driven by new product launches.
- 04/24/2024
|
Durable Goods Orders Came In Line With Expectations
- Pre-market futures are mixed at this hour. Halfway through a week that looks determined to claw back some of the losses incurred over the previous couple weeks, the Dow is giving back -50 points, the S&P 500 is up +11 and the Nasdaq +113 points.
- 04/24/2024
|
Thermo Fisher Scientific Inc. (TMO) Q1 2024 Earnings Call Transcript
- Thermo Fisher Scientific Inc. (NYSE:TMO ) Q1 2024 Earnings Call Transcript April 24, 2024 8:30 AM ET Company Participants Rafael Tejada - VP, IR Marc Casper - Chairman, President and CEO Stephen Williamson - SVP and CFO Conference Call Participants Doug Schenkel - Wolfe Research Mike Ryskin - Bank of America Jack Meehan - Nephron Research Rachel Vatnsdal - JPMorgan Dan Brennan - TD Cowen Matt Sykes - Goldman Sachs Luke Sergott - Barclays Operator Good morning, ladies and gentlemen, and welcome to the Thermo Fisher Scientific 2024 First Quarter Conference Call. My name is Angela, and I'll be coordinating your call today.
- 04/24/2024
|
Boeing Mixed in Q1, TMO Beats; Durable Goods In-Line
- Boeing posted a slimmer loss per share while Thermo Fisher outperformed. Durable Goods performed as expected.
- 04/24/2024
|
Compared to Estimates, Thermo Fisher (TMO) Q1 Earnings: A Look at Key Metrics
- Although the revenue and EPS for Thermo Fisher (TMO) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- 04/24/2024
|
Thermo Fisher lifts profit forecast as medical equipment demand improves
- Thermo Fisher on Wednesday beat Wall Street estimates for quarterly profit and raised its annual profit forecast, betting on improved demand for its products and services used in drug development and sending shares up about 4% premarket.
- 04/24/2024
|
Thermo Fisher Scientific to Host Investor Day
- WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, will hold its 2024 Investor Day on Thursday, September 19, starting at 9:00 a.m. (ET) in New York City. The format will feature presentations by members of Thermo Fisher Scientific's senior management team and conclude with a Q&A session. The live webcast of the presentation can be accessed via the Investors section of our website, www.thermofisher.com. A replay of the webcast wi.
- 04/24/2024
|
Thermo Fisher Scientific Reports First Quarter 2024 Results
- WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the first quarter ended March 30, 2024. First Quarter 2024 Highlights First quarter revenue was $10.34 billion. First quarter GAAP diluted earnings per share (EPS) increased 4% to $3.46. First quarter adjusted EPS increased 2% to $5.11. Advanced our proven growth strategy, launching a range of high-impact, innovative new products during the qu.
- 04/24/2024
|
What's in Store for These 4 Medical Products Stocks in Q1 Earnings?
- Medical Products companies' quarterly results are likely to reflect a year-over-year decline in earnings. Let's see how BSX, TMO, ALGN and ICLR fare this time.
- 04/23/2024
|
Seeking Clues to Thermo Fisher (TMO) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics
- Evaluate the expected performance of Thermo Fisher (TMO) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
- 04/19/2024
|
TMO vs. IDXX: Which Stock Is the Better Value Option?
- Investors looking for stocks in the Medical - Instruments sector might want to consider either Thermo Fisher Scientific (TMO) or Idexx Laboratories (IDXX). But which of these two stocks offers value investors a better bang for their buck right now?
- 04/18/2024
|
What's in Store for Thermo Fisher (TMO) in Q1 Earnings?
- Strength in Analytical Instrument and Laboratory Products and Services segments are likely to have driven Thermo Fisher's (TMO) first-quarter 2024 performance.
- 04/15/2024
|
Thermo Fisher Scientific Introduces Animal Origin-Free Formulation to Support Scaling of Cell Therapy Manufacturing
- WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, has introduced the Gibco™ CTS™ OpTmizer™ One Serum-Free Medium (CTS OpTmizer One SFM)*, a novel animal origin-free (AOF) formulation designed specifically for clinical and commercial cell therapy manufacturing to deliver increased scalability and performance of T cell expansion. As a result, cell therapy manufacturers can use CTS OpTmizer One SFM to help optimize their workflows and get T cell t.
- 04/11/2024
|
7 Healthcare Stocks to Keep Your Portfolio in Tip-Top Shape
- With rising concerns in the market potentially forcing a strategic shift, investors may want to consider healthcare stocks. No matter what happens, people need access to health-related products and services.
- 04/10/2024
|
Thermo Fisher Layoffs 2024: What to Know About the Latest TMO Job Cuts
- Thermo Fisher (NYSE: TMO ) layoffs are in the news Tuesday after the biopharma services company announced job cuts at its California plasmid manufacturing location. According to these latest reports, Thermo Fisher is going to cut 74 jobs from the facility starting May 31, 2024.
- 04/09/2024
|
Thermo Fisher (TMO) Launches TSX Universal Series ULT Freezers
- Thermo Fisher's (TMO) new ENERGY STAR-certified TSX Universal Series ULT Freezers deliver tighter temperature control and faster recovery times.
- 04/09/2024
|
Thermo Fisher Scientific Inc. (TMO) is Attracting Investor Attention: Here is What You Should Know
- Thermo Fisher (TMO) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
- 04/04/2024
|
Final Trades: GXO Logistics, Thermo Fisher & Nasdaq
- The Investment Committee gives you their top stocks to watch for the second half.
- 04/03/2024
|
Thermo Fisher (TMO) Debuts a New In-Line Metrology Solution
- Thermo Fisher's (TMO) new LInspector Edge In-line Mass Profilometer delivers real-time, full-coverage mass loading analysis for battery electrode coating.
- 04/02/2024
|
Here's Why Investors Should Retain Thermo Fisher (TMO) Stock
- Strength in end markets and strategic collaborations bode well for Thermo Fisher (TMO).
- 03/28/2024
|
Thermo Fisher Scientific (TMO) Exceeds Market Returns: Some Facts to Consider
- In the closing of the recent trading day, Thermo Fisher Scientific (TMO) stood at $579.37, denoting a +1.85% change from the preceding trading day.
- 03/27/2024
|
Thermo Fisher Scientific (TMO) Falls More Steeply Than Broader Market: What Investors Need to Know
- Thermo Fisher Scientific (TMO) concluded the recent trading session at $568.82, signifying a -0.83% move from its prior day's close.
- 03/26/2024
|
Thermo Fisher Scientific (TMO) Stock Declines While Market Improves: Some Information for Investors
- In the closing of the recent trading day, Thermo Fisher Scientific (TMO) stood at $580.05, denoting a -0.46% change from the preceding trading day.
- 03/20/2024
|
Thermo Fisher Scientific (TMO) Stock Falls Amid Market Uptick: What Investors Need to Know
- Thermo Fisher Scientific (TMO) reachead $580.05 at the closing of the latest trading day, reflecting a -0.7% change compared to its last close.
- 03/18/2024
|
3 Nanotechnology Stocks That Could Soar as the Technology Advances
- A rapidly growing field, nanotechnology deals with the manipulation of matter at the atomic and molecular scale. This allows for the creation of materials and technological applications beyond the size of standard microelectronics or chemical structures.
- 03/14/2024
|
Thermo Fisher Scientific Inc. (TMO) Is a Trending Stock: Facts to Know Before Betting on It
- Recently, Zacks.com users have been paying close attention to Thermo Fisher (TMO). This makes it worthwhile to examine what the stock has in store.
- 03/14/2024
|
Calls of the Day: Regeneron, Thermo Fisher, Darden Restaurants and Nucor
- The Investment Committee debate the latest calls of the day on a number of stocks.
- 03/13/2024
|
Thermo Fisher Scientific (TMO) Stock Falls Amid Market Uptick: What Investors Need to Know
- In the latest trading session, Thermo Fisher Scientific (TMO) closed at $597.25, marking a -0.36% move from the previous day.
- 03/12/2024
|
Thermo Fisher (TMO) Unveils CorEvitas Clinical Registry in GPP
- Thermo Fisher's (TMO) new CorEvitas clinical registry addresses an unmet need for real-world evidence related to the clinical and patient-reported outcomes of patients with GPP.
- 03/11/2024
|
Thermo Fisher Scientific (TMO) Exceeds Market Returns: Some Facts to Consider
- Thermo Fisher Scientific (TMO) reachead $591.50 at the closing of the latest trading day, reflecting a +1.18% change compared to its last close.
- 03/06/2024
|
Trade Tracker: Jim Lebenthal sells Thermo Fisher
- Jim Lebenthal, chief equity strategist at Cerity Partners, joins CNBC's 'Halftime Report' to explain why he sold Thermo Fisher.
- 03/04/2024
|
Why Is Thermo Fisher (TMO) Up 3.3% Since Last Earnings Report?
- Thermo Fisher (TMO) reported earnings 30 days ago. What's next for the stock?
- 03/01/2024
|
Investors Heavily Search Thermo Fisher Scientific Inc. (TMO): Here is What You Need to Know
- Thermo Fisher (TMO) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
- 03/01/2024
|
Final Trades: Thermo Fisher, Samsara and IYR
- Today's ‘Halftime Report' Investment Committee, Karen Firestone, Shannon Saccocia and Josh Brown give their top picks to watch for the second half.
- 02/29/2024
|
Thermo Fisher (TMO) Introduces Dionex Inuvion IC system
- Thermo Fisher's (TMO) Dionex Inuvion system helps labs operate more effectively by providing simple, adjustable workflows and a small footprint.
- 02/19/2024
|
10 Dividend Growth Stocks: February 2024
- In this series, I rank a selection of dividend growth stocks in Dividend Radar and present the ten top-ranked stocks for consideration. To rank stocks, I do a quality assessment and sort stocks by quality scores, breaking ties with additional metrics. This month, I'm presenting candidates with high earnings, revenue, and dividend growth rates trading at favorable valuations. Additionally, the stocks all have 5-year trailing total returns above 10%.
- 02/19/2024
|
Final Trades: West Pharma, Sonos, Thermo Fisher and TransDigm
- Today's “Halftime Report” Investment Committee, Steve Weiss, Joe Terranova, Brian Belski and Karen Firestone give their top picks to watch for the second half.
- 02/07/2024
|
Buy Alert: 3 Stocks Sitting in the Sweet Spot
- An investment sweet spot is often informally defined as the ideal entry point for buying based on recent macroeconomic developments. Technically, it's a price entry point that guarantees maximum profits or a high probability of a successful reversal trade.
- 01/31/2024
|
Thermo Fisher falls after results beat the Street, investors 'sell the news'
- Shares in Thermo Fisher Scientific (NYSE:TMO) fell despite the lab equipment maker reporting higher revenue and profit than analysts expected. Fourth-quarter revenue of $10.9 billion just beat Wall Street forecasts of $10.74 billion, per Zacks.
- 01/31/2024
|
Thermo Fisher (TMO) Q4 Earnings Top Estimates, Gross Margin Down
- Strength in PPI business contributed to Thermo Fisher's (TMO) fourth-quarter revenue growth.
- 01/31/2024
|
Thermo Fisher (TMO) End Market Growth Strong Despite Macro Woes
- Thermo Fisher's (TMO) electron microscopy, chromatography and mass spectrometry businesses are delivering strong growth in the academic and government end market.
- 01/31/2024
|
Thermo Fisher Scientific Inc. (TMO) Q4 2023 Earnings Call Transcript
- Thermo Fisher Scientific Inc. (TMO) Q4 2023 Earnings Call Transcript
- 01/31/2024
|
Thermo Fisher (TMO) Reports Q4 Earnings: What Key Metrics Have to Say
- The headline numbers for Thermo Fisher (TMO) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
- 01/31/2024
|
Thermo Fisher Scientific (TMO) Tops Q4 Earnings and Revenue Estimates
- Thermo Fisher Scientific (TMO) came out with quarterly earnings of $5.67 per share, beating the Zacks Consensus Estimate of $5.64 per share. This compares to earnings of $5.40 per share a year ago.
- 01/31/2024
|
Thermo Fisher forecasts 2024 profit below estimates on biotech demand slump
- Medical equipment maker Thermo Fisher Scientific Inc on Wednesday forecast annual profit below Wall Street estimates, as it expects that a slump in demand for its services used to make therapeutics and vaccines to continue this year.
- 01/31/2024
|
Thermo Fisher (TMO) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates
- Beyond analysts' top -and-bottom-line estimates for Thermo Fisher (TMO), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2023.
- 01/26/2024
|
Thermo Fisher Scientific (TMO) Laps the Stock Market: Here's Why
- Thermo Fisher Scientific (TMO) closed at $553.39 in the latest trading session, marking a +0.3% move from the prior day.
- 01/22/2024
|
Here's Why Investors Should Retain Thermo Fisher (TMO) Stock
- Investors continue to be optimistic about Thermo Fisher (TMO) due to its series of new product launches and promising growth strategy.
- 01/17/2024
|
What's in Store for Thermo Fisher (TMO) in Q4 Earnings?
- Thermo Fisher (TMO) will likely gain from strong Analytical Instrument business performance and the latest strategic pacts.
- 01/16/2024
|
Thermo Fisher Scientific (TMO) Stock Slides as Market Rises: Facts to Know Before You Trade
- The latest trading day saw Thermo Fisher Scientific (TMO) settling at $544.32, representing a -0.31% change from its previous close.
- 01/12/2024
|
Thermo Fisher Scientific, Inc. (TMO) 42nd Annual J.P. Morgan Healthcare Conference Transcript
- Thermo Fisher Scientific, Inc. (TMO) 42nd Annual J.P. Morgan Healthcare Conference Transcript
- 01/09/2024
|
Thermo Fisher Scientific (TMO) Stock Drops Despite Market Gains: Important Facts to Note
- Thermo Fisher Scientific (TMO) reachead $531.23 at the closing of the latest trading day, reflecting a -1.14% change compared to its last close.
- 01/05/2024
|
Thermo Fisher halts forensic tech sales in Tibet
- Thermo Fisher Scientific has pledged to stop selling forensic technology and equipment in Tibet that could be used for identifying individuals, a spokesperson for the company said.
- 01/05/2024
|
Forget Quantum-Si Stock, Olink Acquirer Thermo Fisher Is a Better Long-Term Investment
- Quantum-Si has a ton of promise if the proteomics market continues to develop. Thermo Fisher indicated the future potential with its big pending acquisition of Olink.
- 12/30/2023
|
Thermo Fisher (TMO) Unveils CorEvitas Pharmacovigilance Platform
- Thermo Fisher (TMO) introduces the CorEvitas pharmacovigilance platform for clinical research registries.
- 12/26/2023
|
Thermo Fisher's (TMO) PPD Business Backs BARDA's Clinical Trial
- Thermo Fisher's (TMO) PPD clinical research business is selected by BARDA to support the Phase II platform clinical trial to treat ARDS.
- 12/22/2023
|
Why Thermo Fisher Scientific (TMO) Dipped More Than Broader Market Today
- Thermo Fisher Scientific (TMO) reachead $519.43 at the closing of the latest trading day, reflecting a -1.65% change compared to its last close.
- 12/20/2023
|
Thermo Fisher (TMO) to Allocate IFA Testing Kits With New Pact
- Thermo Fisher (TMO) will continue to meet the evolving needs of laboratories and healthcare professionals by expanding its immunology product portfolio of EliA autoimmune diagnostics.
- 12/18/2023
|
Thermo Fisher Scientific (TMO) Laps the Stock Market: Here's Why
- Thermo Fisher Scientific (TMO) reachead $521.52 at the closing of the latest trading day, reflecting a +0.57% change compared to its last close.
- 12/14/2023
|
Thermo Fisher (TMO) Launches New Solutions for Clinical Labs
- Thermo Fisher (TMO) introduces the KingFisher Apex Dx system and Applied Biosystems MagMAX Dx Isolation Kit to improve preanalytical workflows for clinical laboratories.
- 12/12/2023
|
New Strong Sell Stocks for December 6th
- AESI, EQH and TMO have been added to the Zacks Rank #5 (Strong Sell) List on December 6, 2023.
- 12/06/2023
|
Thermo Fisher (TMO) Advances Health Equity via New Partnership
- Thermo Fisher (TMO) announces a collaboration with Project HOPE to improve health outcomes by enabling expanded access to HIV testing and support services in Nigeria.
- 12/04/2023
|
Thermo Fisher Scientific: A Good Buy Near The Bottom
- Thermo Fisher Scientific is facing temporary revenue headwinds due to reduced COVID-19-related sales and cautious customer spending. The company's organic revenues are expected to bottom in FY24 and see a reacceleration in growth from FY25 onwards which can help the stock re-rate. TMO's valuation is cheap compared to historical averages and peers, offering a good buying opportunity.
- 12/03/2023
|
Thermo Fisher (TMO) Extends Partnership With Flagship Pioneering
- Thermo Fisher's (TMO) in-depth knowledge of the life sciences sector will be combined with Flagship Pioneering to create revolutionary capabilities for the ecosystem.
- 11/30/2023
|
3 High Dividend Growth Stocks to Buy in December 2023
- After a downturn that ran from late summer to early fall, the stock market reversed higher on two pieces of good news. First, inflation seems to have stabilized.
- 11/27/2023
|
Thermo Fisher Scientific reveals new $4B stock buyback program
- Thermo Fisher Scientific (NYSE:TMO) Inc has announced a new $4 billion stock repurchase program, which represents about 2.3% of its market capitalization of $171.99 billion as of Monday's close. The analytics, diagnostics and laboratory services company said the new buyback program, which has no expiration date, replaces the existing program that had $1 billion in repurchase authorization remaining.
- 11/14/2023
|
Thermo Fisher sets new $4 billion stock buyback program, about 2 weeks after shares hit a 3-year low
- Shares of Thermo Fisher Scientific Inc. TMO, -0.73% were little changed in premarket trading Tuesday, after the analytics, diagnostics and laboratory services company announced a new $4 billion stock repurchase program. The new program represents about 2.3% of the company's market capitalization of $171.99 billion as of Monday's close.
- 11/14/2023
|
Down 19% in 2023 So Far, Is Thermo Fisher Scientific Stock Still Worth Buying?
- Thermo Fisher is seeing the collapse of its COVID-19 diagnostic business. It's also suffering from its customers tightening their purse strings.
- 11/03/2023
|
Abbott Labs Vs. Thermo Fisher: Which Is The Better Healthcare Stock?
- Thermo Fisher and Abbott are two of our key Healthcare holdings in our fund, and both are among our top 10 holdings overall. Abbott and Thermo Fisher focus on different industries which are Healthcare Equipment and Life Science Tools respectively. Both show strong revenue growth compared to the market average growth rate which indicates that both companies exhibit competitive advantages within their respective main markets.
- 11/01/2023
|
3 Beaten-Down Dividend Stocks You Could Regret Not Buying on the Dip
- Ally Financial is a digital bank that offers a dividend yield above 5% at recent prices. Thermo Fisher Scientific's COVID-19 testing revenue has evaporated, but that won't stop the company from raising its dividend payout higher in the years ahead.
- 10/30/2023
|
Thermo Fisher Scientific Inc. (TMO) Q3 2023 Earnings Call Transcript
- Thermo Fisher Scientific Inc. (NYSE:TMO ) Q3 2023 Earnings Call Transcript October 25, 2023 8:30 AM ET Company Participants Rafael Tejada - VP of IR Marc Casper - Chairman, President and CEO Stephen Williamson - SVP and CFO Conference Call Participants Jack Meehan - Nephron Research Dan Brennan - TD Cowen Derik de Bruin - Bank of America Rachel Vatnsdal - J.P. Morgan Puneet Souda - Leerink Partners Eve Burstein - Bernstein Operator Good morning, ladies and gentlemen, and welcome to the Thermo Fisher Scientific 2023 Third Quarter Conference Call.
- 10/25/2023
|
Q3 Earnings Mixed, Big Results Expected After-Hours
- The Dow is the sole major index in the green this morning, boosted by Microsoft's strong performance yesterday afternoon.
- 10/25/2023
|
Thermo Fisher Cuts Its Outlook For Second-Straight Quarter Amid Weakening Market
- Shares of Thermo Fisher Scientific (TMO) slumped over 7% in early trading Wednesday after the maker of lab equipment and analytical instruments posted weaker-than-expected sales and cut its outlook for a second-straight quarter on slowing demand.
- 10/25/2023
|
Thermo Fisher's stock on track for lowest close in more than three years after revenue miss and lowered guidance
- Thermo Fisher Scientific Inc.'s stock TMO, -7.80% fell about 9% Wednesday to put it on track for its lowest close in more than three years, after the supplier of analytics, diagnostics and laboratory services missed revenue estimates for its third quarter and trimmed guidance. The company posted net income of $1.715 billion, or $4.42 a share, for the quarter, up from $1.495 billion, or $3.79 a share, in the year-earlier period.
- 10/25/2023
|
Thermo Fisher lowers profit and sales outlook on soft demand, rising costs
- Thermo Fisher Scientific (NYSE:TMO) issued a forecast for full-year profit and sales that falls below Wall Street expectations on lower-than-expected demand for its services used in the production of therapies and vaccines, as well as increased costs for raw materials. It is the second consecutive quarter in which the company has reduced its annual adjusted profit expectations.
- 10/25/2023
|
Thermo Fisher Scientific (TMO) Beats Q3 Earnings and Revenue Estimates
- Thermo Fisher Scientific (TMO) came out with quarterly earnings of $5.69 per share, beating the Zacks Consensus Estimate of $5.58 per share. This compares to earnings of $5.08 per share a year ago.
- 10/25/2023
|
Thermo Fisher Stock Slumps After Sales Miss and Outlook Is Slashed Again
- The leading maker of scientific equipment slashes its guidance for the second consecutive quarter, citing a challenging macro environment.
- 10/25/2023
|
Thermo Fisher cuts annual profit forecast on weak biotech demand
- Medical equipment maker Thermo Fisher Scientific on Wednesday cut its annual profit forecast for the second straight quarter, hurt by lower-than-expected demand for its services used to make therapeutics, vaccines and analytical tools.
- 10/25/2023
|
Olink Holding stock soars on acquisition by Thermo Fisher Scientific
- Olink Holding AB shares surged 66% to $24.87 in late-morning trading on Tuesday after the provider of next-generation proteomics solutions announced that it has agreed to be acquired by Thermo Fisher Scientific (NYSE:TMO) Inc for $26 per share in cash, representing a premium of about 74% to the closing price of Olink's Nasdaq-listed American Depositary Shares (ADS) on October 16, 2023. The transaction values Olink at approximately $3.1 billion, which includes net cash of about $143 million.
- 10/17/2023
|
Why Olink Stock Is Skyrocketing Today
- Thermo Fisher Scientific plans to acquire Olink for $3.1 billion. The deal would add Olink's proteomics technology to Thermo Fisher's life sciences solutions.
- 10/17/2023
|
Thermo Fisher to Buy Sweden's Olink for $3.1 Billion
- Thermo Fisher will acquire proteomics company Olink for $26 per American depositary share in cash.
- 10/17/2023
|
Thermo Fisher's stock slips after deal to buy Sweden's Olink for a 74% premium
- Thermo Fisher Scientific Inc. TMO, +1.18% announced Tuesday an agreement to buy Sweden-based proteomics company Olink Holding AB OLK, +0.47% in a deal that values Olink at about $3.1 billion, including $143 million in cash. Olink's stock was halted for news until 8:50 a.m.
- 10/17/2023
|
Here's Why Investors Should Retain Thermo Fisher (TMO) Stock
- Investors continue to be optimistic about Thermo Fisher (TMO) due to its impressive acquisition deals and end-market strength.
- 10/16/2023
|
Thermo Fisher's (TMO) Strong End Markets and New Buyouts Aid
- Thermo Fisher (TMO) is registering strong growth in the electron microscopy and chromatography and mass spectrometry businesses in the academic and government end market.
- 10/10/2023
|
Thermo Fisher Scientific (TMO) Increases Yet Falls Behind Market: What Investors Need to Know
- The latest trading day saw Thermo Fisher Scientific (TMO) settling at $498.55, representing a +0.11% change from its previous close.
- 10/06/2023
|
Thermo Fisher (TMO) Expands Capabilities in St. Louis Facility
- Thermo Fisher (TMO) expands manufacturing capacity at the St. Louis site for Biologics treatment.
- 10/06/2023
|
Harbor Capital Appreciation Fund Adds to Tech Holdings, Exits Energy Space
- The Harbor Capital Appreciation Fund (Trades, Portfolio) disclosed its equity portfolio for the third quarter of 2023 last week.
- 10/05/2023
|
Stable Giants: 3 Bigwig Biotech Stocks for Consistent Returns
- Biotech stocks have had a rough post-pandemic. In a year where the S&P500 is up more than 10% year to date, the biotech sector is still negative to flat.
- 10/02/2023
|
Thermo Fisher Scientific: Transforming Healthcare Leadership Post-COVID-19 Pandemic
- Thermo Fisher Scientific is a leading research and development company and provider of laboratory products and services headquartered in Waltham. On August 23, Reuters announced that Novo Nordisk has entered into a partnership agreement with Thermo Fisher Scientific, under which it will be responsible for filling the Wegovy injection pens. Moreover, Thermo Fisher Scientific's Non-GAAP P/E [TTM] is 24.35x, which is 32.17% higher than the sector average and 1.1% lower than the average over the past five years.
- 09/30/2023
|
Thermo Fisher: I'm Waiting For A Better Valuation In This High-Quality Business
- Thermo Fisher Scientific provides laboratory instruments, reagents, and consumables for scientific research and healthcare applications. These are the 'picks and shovels' for healthcare and life sciences sectors. Thermo Fisher generates recurring revenue through the adoption of single-use systems in the pharmaceutical industry, increasing. The current valuation offers me an annualized return of between 8% and 9% over the next 5 years, so I decided to assign a 'hold' rating.
- 09/30/2023
|
Will Thermo Fisher Scientific Stock Recover To Its Pre-Inflation Shock Highs?
- This underperformance of TMO stock can partly be attributed to declining sales of its Life Sciences segment due to lower COVID-19-related demand.
- 09/12/2023
|
Thermo Fisher (TMO) to Advance Clinical Research With New Pact
- Thermo Fisher's clinical research division will aid in increasing community health clinics' capacity to participate in clinical studies.
- 09/11/2023
|
Thermo Fisher (TMO) Adds New Platform to CTS Product Portfolio
- Thermo Fisher (TMO) launches the next-generation Gibco CTS Detachable Dynabeads platform.
- 09/08/2023
|
Call of the day: The health care trade
- CNBC's Halftime traders Steve Weiss, Liz Young, Joe Terranova, and Brian Belski discuss the call of the day: health care.
- 09/06/2023
|
Is Abbott Stock A Better Healthcare Pick Over Thermo Fisher Scientific?
- There is more to the comparison, and in the sections below, we discuss why we believe that TMO will offer better returns than ABT in the next three years.
- 09/06/2023
|
Robo-Lab Stocks: 3 Robotics Companies Changing the Research Game
- Here's a look at 3 leading robo-lab company stocks. When you think of dexterous professions, you often think of doctors or musicians.
- 09/04/2023
|
7 Stocks Hedge Funds Are Loading Up On
- Emulating the moves of hedge fund stock pickers, and some of the most successful hedge funds can produce sizable profits for retail investors. In fact, here are seven of the top institutional stock picks you may want to consider as we near the last few months of 2023.
- 09/03/2023
|
Why Is Thermo Fisher (TMO) Down 3.9% Since Last Earnings Report?
- Thermo Fisher (TMO) reported earnings 30 days ago. What's next for the stock?
- 08/25/2023
|
Thermo Fisher's (TMO) EXTENT Solution Makes Commercial Launch
- Thermo Fisher (TMO) announces the commercial launch of the EXTENT Solution with IVDR certification.
- 08/25/2023
|
Thermo Fisher Scientific to Present at Handelsbanken 3rd Annual Life Science Innovation Day on August 30th, 2023
- WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present at the Handelsbanken 3rd Annual Life Science Innovation Day on Wednesday, August 30th, 2023 at 10:00 a.m. (EDT). You can access the webcast of the presentation via the Investors section of our website, www.thermofisher.com. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the w.
- 08/25/2023
|
3 Millionaire-Maker Robotics Stocks to Hold Through Thick and Thin
- The world is becoming increasingly automated paving the way for robotics stocks moving forward. Sector growth is expected to reach double digits on an annualized basis and ranges from the low to mid-teens depending on the source In either case, capital invested in the sector has a reasonable chance of increasing in value.
- 08/24/2023
|
Thermo Fisher (TMO) Launches New Chromosomal Microarray
- Thermo Fisher's (TMO) CytoScan HD Accel array can save labs weeks or even months by accelerating the time it takes to get findings from cytogenetic research.
- 08/23/2023
|
Novo hires Thermo Fisher as 2nd manufacturer for Wegovy weight-loss drug - source
- Novo Nordisk has hired Thermo Fisher as its second contract manufacturer for its hugely popular weight-loss drug Wegovy, a source familiar with the matter told Reuters.
- 08/23/2023
|
Thermo Fisher (TMO) Business Hurt by Low COVID Sales, FX Woe
- Thermo Fisher (TMO) is witnessing headwinds in the government and academic end markets.
- 08/18/2023
|
Thermo Fisher (TMO) Completes the CorEvitas Acquisition
- Thermo Fisher's (TMO) latest buyout is likely to deliver $0.03 in adjusted earnings per share in 2024 and be marginally accretive in 2023.
- 08/16/2023
|
Biotech Bonanza: 3 Top DNA Stocks With Revolutionary Potential
- DNA is as fundamental to biotechnology as it is to biology itself. From synthetic biology to pharmaceuticals, making and using DNA is usually a necessary first step in bringing a biotech product to market.
- 08/11/2023
|
The 3 Best Healthcare Stocks to Buy in August
- Health is undoubtedly the most important thing for all of us. It's vital to be able to continue with our day-to-day and to be able to carry out everything we want to throughout our lives.
- 08/09/2023
|
Is This Healthcare Stock a Buy for Growth Investors?
- Headwinds in Q2 led Thermo Fisher Scientific's revenue and profits lower. The company's dividend should have tons of room to grow over the long haul.
- 08/06/2023
|
Time To Go Defensive With These ETFs
- High-beta stocks have outperformed defensive stocks in the stock market recently, raising questions about the effectiveness of low-volatility and dividend growth investing. ROBECO's research shows that low-volatility investing can significantly improve long-term performance, particularly in market environments with increased retail investor participation. Low-risk ETFs, such as healthcare names and dividend aristocrats, offer exposure to fundamentally strong factors and tend to perform well during periods of stagflation, high inflation, and decent economic growth.
- 08/02/2023
|
Thermo Fisher settles Henrietta Lacks lawsuit over 'HeLa' cell line
- Laboratory equipment maker Thermo Fisher Scientific has settled a lawsuit brought by the estate of Henrietta Lacks, whose cells have fueled biomedical research for decades, lawyers for the estate said on Tuesday.
- 08/01/2023
|
Thermo Fisher (TMO) Q2 Earnings Miss Estimates, Margins Down
- Challenging macroeconomic conditions and slowdown in activities in China impede Thermo Fisher's (TMO) Q2 revenues.
- 07/26/2023
|
Thermo Fisher (TMO) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
- While the top- and bottom-line numbers for Thermo Fisher (TMO) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
- 07/26/2023
|
Thermo Fisher stock slumps on depressed profit forecast
- Shares of Thermo Fisher Scientific (NYSE:TMO) fell Wednesday morning after the medical equipment manufacturer slashed its annual profit forecast. The company dropped its full-year earnings projection to between $22.28 and $22.72 per share, compared to its previous forecast of $23.70.
- 07/26/2023
|
Thermo Fisher Scientific (TMO) Lags Q2 Earnings and Revenue Estimates
- Thermo Fisher Scientific (TMO) came out with quarterly earnings of $5.15 per share, missing the Zacks Consensus Estimate of $5.43 per share. This compares to earnings of $5.51 per share a year ago.
- 07/26/2023
|
Thermo Fisher stock drops after company trims full-year outlook
- Thermo Fisher Scientific Inc. TMO, -0.11% shares fell more than 5% premarket on Wednesday after the medical device and lab equipment maker trimmed its full-year earnings and revenue guidance. “The macroeconomic environment became more challenging in the second quarter,” CEO Marc Casper said in a statement, as economic activity in China slowed and businesses across the economy became more cautious in their spending.
- 07/26/2023
|
Thermo Fisher cuts 2023 forecast as biotech funding woes linger
- Medical equipment maker Thermo Fisher Scientific on Wednesday cut its annual profit forecast, hurt by weak demand for its biopharma services including tools and compounds used to make therapeutics and vaccines.
- 07/26/2023
|
What's in Store for Thermo Fisher (TMO) in Q2 Earnings?
- Thermo Fisher (TMO) is likely to have generated growth in the second quarter, driven by a favorable business mix and new launches.
- 07/18/2023
|
10 Dividend Growth Stocks For July 2023
- The article presents a monthly series of 10 top-ranked dividend growth stocks for further research and potential investment. The stocks are ranked based on quality scores, with tie-breaking metrics including dividend safety scores, credit ratings, and forward dividend yield. The top three stocks for this month are Visa, UnitedHealth, and Intercontinental Exchange. The article also provides key metrics and fair value estimates for each stock, and suggests that Tractor Supply Company passes all selection criteria for adding new positions to the author's DivGro portfolio.
- 07/15/2023
|
Thermo Fisher (TMO) Launches Diomni Enterprise Software
- Thermo Fisher's (TMO) Diomni Enterprise Software effortlessly connects each individual processing stage to a single, integrated platform.
- 07/14/2023
|
Why Thermo Fisher Is More Than a Pandemic Play
- Laboratories increasingly need the specialized instruments and services that Thermo Fisher provides.
- 07/13/2023
|
Final Trades: Broadcom, Conocophillips, Thermo Fisher
- The "Halftime Report" traders give their top picks to watch for the second half.
- 07/12/2023
|
Thermo Fisher (TMO) Announces the Acquisition of CorEvitas
- Thermo Fisher's (TMO) acquisition of CorEvitas is likely to strengthen its value proposition.
- 07/10/2023
|
Thermo Fisher Scientific: Continuing To Add To The Fortress
- Thermo Fisher is a great life science giant which is battling tough comparables with pandemic-related revenues on their retreat. I like the historical achievements, but with growth being flattish, valuations are full (given where interest rates are). I like the business in the long haul, but would like to see a $4 handle before initiating a position.
- 07/09/2023
|
Will Thermo Fisher (TMO) Beat Estimates Again in Its Next Earnings Report?
- Thermo Fisher (TMO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 07/06/2023
|
Thermo Fisher Scientific to acquire data intelligence provider CorEvitas
- Thermo Fisher Scientific (NYSE:TMO) Inc on Thursday announced it would acquire data intelligence company CorEvitas from Audax Private Equity for $912.5 million in cash. CorEvitas is a provider of data and analytics to pharmaceutical and biotech companies and expects revenue of $110 million in 2023, Reuters reported.
- 07/06/2023
|
Thermo Fisher buying CorEvitas for $912.5 mln
- Thermo Fisher Scientific Inc. TMO said Thursday it agreed to pay $912.5 million in cash for Waltham, Mass.-based CorEvitas LLC, a provider of “regulatory-grade” evidence for approved medical treatments and therapies, from seller Audax Private Equity.
- 07/06/2023
|
Thermo Fisher: A Master Compounder In Healthcare
- Thermo Fisher Scientific is a leading healthcare supplier with strong customer relationships and a track record of impressive revenue and net income growth. TMO's superior business model, focused on innovation and serving scientific customers, positions it for long-term growth and outperformance in the healthcare sector. Despite a challenging first quarter, TMO maintains a confident outlook, and its valuation, although not cheap, is justified by expectations of double-digit annual earnings growth.
- 07/02/2023
|
Thermo Fisher's (TMO) New Launch to Advance Cancer Therapies
- Thermo Fisher's (TMO) Gibco OncoPro Tumoroid Culture Medium Kit is intended to increase researchers' access to sophisticated cancer models.
- 06/30/2023
|
3 Healthcare Stocks That Are Too Cheap to Ignore
- CVS should benefit from rising demand for health insurance and medications. Thermo Fisher Scientific is a key provider of medical supplies to the drug industry.
- 06/25/2023
|
Ready for a Rebound: 7 Blue-Chips Set to Regain Their Market Mojo
- While the smaller-capitalization trades tend to attract the most speculative attention, for reliable upside prospects, investors may want to consider blue-chip stocks to buy. To better understand the motivation behind targeting these stalwarts, a baseball analogy may be helpful.
- 06/20/2023
|
Here's Why Investors Should Retain Thermo Fisher (TMO) Stock
- Investors continue to be optimistic about Thermo Fisher's (TMO) continued strength across its end markets and the the execution of the growth strategy.
- 06/07/2023
|
Thermo Fisher's (TMO) Unveils Orbitrap Astral Spectrometer
- Thermo Fisher's (TMO) OrbitrapTM AstralTM mass spectrometer enables accurate and exact quantification in proteomics laboratories.
- 06/06/2023
|
Buy Thermo Fisher, But With Caution
- Thermo Fisher Scientific has experienced significant growth over the past 20 years, with a 14% CAGR in revenue and a 17% CAGR in adjusted EPS. Despite headwinds from the COVID-19 pandemic and inflation, the company maintains strong guidance for 2023, with a focus on rewarding shareholders through dividends and buybacks. TMO stock is currently trading at a premium but for good reasons. Today's price is still a good entry point but I would recommend to add only on weakness.
- 05/31/2023
|
Thermo Fisher Scientific Inc. (TMO) Bernstein 39th Annual Strategic Decisions Conference - (Transcript)
- Thermo Fisher Scientific Inc. (NYSE:TMO ) Bernstein 39th Annual Strategic Decisions Conference Call May 31, 2023 11:00 AM ET Company Participants Marc Casper - Chairman, President and Chief Executive Officer Conference Call Participants Eve Burstein - Bernstein Eve Burstein All right. Good morning, everyone.
- 05/31/2023
|
Final Trades: CrowdStrike, Salesforce, Thermo Fisher & more
- The "Halftime Report" traders give their top picks to watch for the second half.
- 05/25/2023
|
Thermo Fisher (TMO) Expands Manufacturing Facility in APAC
- Thermo Fisher (TMO) latest expansion will enable it to better assist clients in accelerating their research, development and marketing of medications and vaccines in the Asia-Pacific region.
- 05/24/2023
|
Thermo Fisher (TMO) Gets FDA Clearance for Its Immunoassays
- Thermo Fisher (TMO) announces the FDA clearance of its blood-based biomarkers used in the determination of risk assessment and clinical management of preeclampsia with severe features.
- 05/22/2023
|
Thermo Fisher receives FDA clearance for preeclampsia risk assessment tool
- Thermo Fisher Scientific (NYSE:TMO) announced that the U.S. Food and Drug Administration (FDA) has cleared its Thermo Scientific B·R·A·H·M·S PlGF plus KRYPTOR and B·R·A·H·M·S sFlt-1 KRYPTOR immunoassays.
- 05/19/2023
|
Thermo Fisher's preeclampsia blood test wins FDA clearance
- The U.S. Food and Drug Administration (FDA) has cleared the first test to detect women with risk of severe preeclampsia, a leading cause of pregnancy-related illness and death in the United States, Thermo Fisher Scientific Inc said on Friday.
- 05/19/2023
|
Thermo Fisher Scientific Inc. (TMO) CEO presents at BofA Securities 2023 Healthcare Conference Call (Transcript)
- Thermo Fisher Scientific Inc.
- 05/14/2023
|
The 3 Most Promising Nanotechnology Stocks to Buy
- Nanotechnology refers to technologies based on materials between 1 and 100 nanometers in size, which is the microscopic level. Accordingly, the production of such materials from nanotechnology stocks represent impressive upside, for those bullish on certain key industries.
- 05/05/2023
|
This Top Fund Manager Buys Growth Stocks Without Paying Too Much
- Daniel Morris, manager of top mutual fund Manor Growth Fund (MNRGX), admits he has a conservative streak. The post This Top Fund Manager Buys Growth Stocks Without Paying Too Much appeared first on Investor's Business Daily.
- 05/05/2023
|
Got $5,000? Buy These 2 Stalwart Stocks and Hold Them Forever
- Stalwarts are companies that have stood the test of time without trouble. Thermo Fisher's recent headwinds should have little impact on its long-term outlook.
- 05/03/2023
|
Thermo Fisher (TMO) Q1 Earnings Beat Estimates, Margins Down
- The year-over-year growth in the Analytical Instruments and the Laboratory Products and Biopharma Services segments drove Thermo Fisher's (TMO) Q1 revenues.
- 04/26/2023
|
Trade Deficit Comes in Lesser Than Expected
- Trade Deficit Comes in Lesser Than Expected.
- 04/26/2023
|
Thermo Fisher Scientific stock declines on Q1 revenue decline
- Yahoo Finance Live anchors Julie Hyman and Brad Smith discuss the decline in stock for Thermo Fisher Scientific.
- 04/26/2023
|
Thermo Fisher takes a hit on dwindling 1Q Covid testing revenue
- Shares of Thermo Fisher Scientific (NYSE:TMO) fell Wednesday morning after the company's first-quarter results revealed declining Covid-19 testing revenue. The Massachusetts-based company posted saw revenue decline 9% year-over-year from $11.82 billion to $10.71 billion, which beat Street expectations of $10.67 billion.
- 04/26/2023
|
Thermo Fisher Scientific (TMO) Tops Q1 Earnings and Revenue Estimates
- Thermo Fisher Scientific (TMO) came out with quarterly earnings of $5.03 per share, beating the Zacks Consensus Estimate of $4.95 per share. This compares to earnings of $7.25 per share a year ago.
- 04/26/2023
|
Thermo Fisher Matches Earnings Estimates. It's Facing a Covid Comedown.
- Thermo Fisher's first-quarter adjusted earnings meet analysts' expectations even as Covid-19 testing revenue falls sharply.
- 04/26/2023
|
Why Thermo Fisher (TMO) is Poised to Beat Earnings Estimates Again
- Thermo Fisher (TMO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 04/24/2023
|
Some of the Top Healthcare Companies Reside in this ETF
- While still sporting a modest year-to-date loss, the S&P 500 Health Care Index is higher by 4.44% over the past month, and with the healthcare sector's reputation for defensive and quality traits, it could be a refuge for market participants if broader market volatility creeps higher.
- 04/22/2023
|
2 Steady Stocks to Buy and Hold Forever
- Selling goods to an industry is sometimes safer than competing with it directly. The biopharma sector simply can't do without Thermo Fisher's products.
- 04/22/2023
|
Bear Market Champions: 2 Resilient Stocks to Weather Any Storm
- It's a good idea to anchor your portfolio with a few stable companies. Thermo Fisher is one of the biggest and most important suppliers in healthcare.
- 04/21/2023
|
What's in Store for Thermo Fisher (TMO) in Q1 Earnings?
- Thermo Fisher (TMO) is likely to have generated growth in the first quarter, driven by a favorable business mix and new launches.
- 04/18/2023
|
TMO vs. ISRG: Which Stock Is the Better Value Option?
- Investors interested in stocks from the Medical - Instruments sector have probably already heard of Thermo Fisher Scientific (TMO) and Intuitive Surgical, Inc. (ISRG). But which of these two stocks presents investors with the better value opportunity right now?
- 04/14/2023
|
Final Trades: Biotech, Defense, Thermo Fisher & more
- The "Halftime Report" traders give their top picks to watch for the second half.
- 04/13/2023
|
Thermo Fisher (TMO) Expands to Boost Commercial Manufacturing
- Thermo Fisher's expansion in Bourgoin is built on the company's investments in small molecule solutions.
- 04/11/2023
|
Final Trades: Abbvie, Thermo Fisher & more
- The "Halftime Report" traders give their top picks to watch for the second half.
- 04/05/2023
|
Thermo Fisher (TMO) Partners With ArsenalBio for Cancer R&D
- Thermo Fisher's (TMO) latest collaboration with ArsenalBio supports the latter's clinical manufacturing of autologous T-cell therapies for advanced cancer treatment.
- 03/30/2023
|
Thermo Fisher: Dividend Stock Brilliance
- In this article, we discuss Thermo Fisher, a low-yielding, fast-growing dividend stock. Hence, I start with a discussion of why low-yield investing can still add value to your dividend portfolio. Thermo Fisher has a wide-moat business model, strong pricing power, anti-cyclical customers, and strong industry growth, which it is likely to outperform.
- 03/30/2023
|
Thermo Fisher (TMO) Opens New Cell Therapy Facility at UCSF
- Thermo Fisher's (TMO) new cell therapy facility at UCSF is likely to accelerate the development of advanced therapies.
- 03/28/2023
|
TMO vs. SONVY: Which Stock Is the Better Value Option?
- TMO vs. SONVY: Which Stock Is the Better Value Option?
- 03/24/2023
|
Exclusive: Thermo Fisher, Celltrion vie for Baxter's biopharma unit -sources
- U.S. scientific instruments maker Thermo Fisher Scientific Inc and South Korea's Celltrion Inc are among
- 03/20/2023
|
Thermo Fisher (TMO) Introduces iCAP RQplus ICP-MS Analyzer
- Thermo Fisher's (TMO) new analyzer streamlines everyday analyses in environmental, food, pharmaceutical and industrial testing laboratories.
- 03/13/2023
|
Thermo Fisher (TMO) Unveils New Line of Low-Flow HPLC Columns
- Thermo Fisher's (TMO) newest addition of a new line of low-flow HPLC columns that improve separation performance and stability of biologically complex samples.
- 03/09/2023
|
TMO or IDXX: Which Is the Better Value Stock Right Now?
- TMO vs. IDXX: Which Stock Is the Better Value Option?
- 03/08/2023
|
Why Is Thermo Fisher (TMO) Down 6.5% Since Last Earnings Report?
- Thermo Fisher (TMO) reported earnings 30 days ago. What's next for the stock?
- 03/03/2023
|
The Dividend Pyramid: Potentially Beat The Market With This 12-Stock Portfolio
- We start with a discussion of diversification theories based on the findings of a scientific article called "The Dividend Puzzle". While inexperienced investors should stick to ETFs, there's a clear case to be made for the behavioral approach, which is based on a mix of different dividend strategies.
- 03/03/2023
|
Thermo Fisher Scientific to Present at Cowen 43rd Annual Healthcare Conference on March 6, 2023
- WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present at the Cowen Healthcare Conference on Monday, March 6, 2023 at 9:10 a.m. (EST). You can access the webcast of the presentation via the Investors section of our website, www.thermofisher.com. About Thermo Fisher Scientific Thermo Fisher Scientific Inc.
- 02/28/2023
|
Got $5,000? These 2 Low-Risk Growth Stocks Also Pay Dividends
- These stocks would have more than doubled your money in the past five years.
- 02/22/2023
|
3 Stocks With Sales Growth to Buy Amid Persistent Inflation
- Sales growth is vital for the survival of a business, even during an economic slowdown. Everest Re (RE), Thermo Fisher (TMO) and Sony Group (SONY) are recording top-line growth.
- 02/21/2023
|
TMO vs. IDXX: Which Stock Is the Better Value Option?
- TMO vs. IDXX: Which Stock Is the Better Value Option?
- 02/20/2023
|
3 Large-Cap Biotech Stocks to Hold for the Long Haul
- Despite the sharp slide in biotech stocks during 2022, the industry is still poised for mega growth. Pandemic preparedness needs better vaccines and disease detection methods.
- 02/19/2023
|
Thermo Fisher (TMO) Rides on Strong End Markets, New Launches
- Thermo Fisher's (TMO) newly-launched Gibco CTS DynaCellect Magnetic Separation System is helping customers advance their cell and gene therapy programs.
- 02/15/2023
|
Dividend Growth Stock Watchlist - February 2023
- There are 21 stocks on my dividend growth watchlist for January 2023. More than half of the stocks on my watchlist for this month are currently undervalued based on dividend yield theory.
- 02/10/2023
|
Is Thermo Fisher Scientific Stock a Buy Now?
- Now that China's concluded its zero-COVID policy, Thermo Fisher Scientific expects rapid growth in its second-largest end market.
- 02/04/2023
|
Thermo Fisher (TMO) Upgraded to Buy: What Does It Mean for the Stock?
- Thermo Fisher (TMO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
- 02/03/2023
|
Thermo Fisher Scientific CEO on 2023 outlook for business in China
- Cramer spoke with Thermo Fisher Scientific CEO Marc Casper on Wednesday.
- 02/01/2023
|
Final Trades: Darden Restaurants, Thermo Fisher & more
- The "Halftime Report" traders give their top picks to watch for the second half.
- 02/01/2023
|
Thermo Fisher Scientific Inc. (TMO) Q4 2022 Earnings Call Transcript
- Thermo Fisher Scientific Inc. (NYSE:TMO ) Q4 2022 Earnings Conference Call February 1, 2023 8:30 AM ET Company Participants Rafael Tejada – Vice President-Investor Relations Marc Casper – Chairman, President and Chief Executive Officer Stephen Williamson – Senior Vice President and Chief Financial Officer Conference Call Participants Jack Meehan – Nephron Research Patrick Donnelly – Citi Rachel Vatnsdal – J.P. Morgan Derik de Bruin – Bank of America Dan Brennan – Cowen Vijay Kumar – Evercore ISI Dan Arias – Stifel Operator Good morning, ladies and gentlemen, and welcome to the Thermo Fisher Scientific 2022 Fourth Quarter Conference Call.
- 02/01/2023
|
Thermo Fisher (TMO) Q4 Earnings Beat Estimates, Margins Down
- Robust year-over-year growth in the Analytical Instruments and the Laboratory Products and Biopharma Services segments boost Thermo Fisher's (TMO) Q4 revenues.
- 02/01/2023
|
Thermo Fisher Pops On Its Bullish Outlook As Boston Scientific Gains On Its In-Line Report
- Thermo Fisher easily beat quarterly projections, while Boston Scientific was in line. TMO stock popped Wednesday while BSX stock also rose.
- 02/01/2023
|
Thermo Fisher Scientific (TMO) Surpasses Q4 Earnings and Revenue Estimates
- Thermo Fisher (TMO) delivered earnings and revenue surprises of 4.05% and 10.55%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
- 02/01/2023
|
10 Biggest Companies Reporting Earnings in the First Week of Feb 2023
- The fourth quarter earnings season for the S&P 500 didn't get off to a strong start.
- 01/25/2023
|
Dividend Growth Checkup - 2022
- Analyzing my real-life portfolio's dividend growth for 2022. Dividend growth pulled back some compared to 2021; however, it was still a strong year of dividend growth.
- 01/25/2023
|
What's in Store for Thermo Fisher (TMO) in Q4 Earnings?
- The industrywide trend of record-level inflation, supply issues and staffing shortages are expected to have deterred growth in several areas of Thermo Fisher's (TMO) business in Q4.
- 01/23/2023
|
Ranking The Diversified Healthcare Giants
- The Top Six Healthcare Products and Service companies are some of the most popular investments in the market. However, they offer varying financial profiles.
- 01/22/2023
|
Dividend Growth Stock Watchlist - January 2023
- There are 17 stocks on my dividend growth watchlist for January 2023. A little more than half of the stocks on my watchlist for this month are currently undervalued based on dividend yield theory.
- 01/14/2023
|
Thermo Fisher Scientific: Growing Diagnosis Market May Provide Upside
- Thermo Fisher operates worldwide selling medical and science laboratories products, software, and services that benefitted from the pandemic but are not beholden to it for profit and momentum. The stock gets low grades for valuation and growth but investors can potentially realize a 20% upside or more in the next 12 months.
- 01/11/2023
|
We Have A Winner! Revisiting Danaher And Thermo Fisher
- In this article, I revisit the life sciences "picks and shovels" market leaders Danaher Corporation and Thermo Fisher Scientific Inc. I will review changes since the initial comparative piece two quarters ago.
- 01/11/2023
|
Thermo Fisher Scientific Inc. (TMO) CEO Marc Casper presents at 41st Annual J.P. Morgan Healthcare Conference (Transcript)
- Thermo Fisher Scientific Inc. (NYSE:TMO ) 41st Annual J.P. Morgan Healthcare Conference January 10, 2023 10:30 AM ET Company Participants Marc Casper - Chairman, President and Chief Executive Officer Conference Call Participants Rachel Vatnsdal - JP Morgan Operator Rachel Vatnsdal Good morning, everyone.
- 01/10/2023
|
Thermo Fisher's (TMO) Monkeypox Test Receives FDA EUA
- Thermo Fisher's (TMO) monkeypox test kit is a PCR test intended to spot non-variola Orthopoxviruses, including the monkeypox virus.
- 12/21/2022
|
Thermo Fisher (TMO) Expands Global Footprint With New Facility
- Thermo Fisher's (TMO) new facility in China is a strategic addition to the company's global pharma services network.
- 12/13/2022
|
Back Up The “Dividend Dump Truck” For These Stocks In '23
- China's over-the-top COVID lockdowns are setting up a surprising “all-American” dividend opportunity for us contrarians.
- 12/07/2022
|
Thermo Fisher (TMO) End Markets Grow Strong, Margin Woe Stays
- Thermo Fisher (TMO) witnesses strength in three of its four end markets, categorized either by customer type or geography.
- 12/05/2022
|
Thermo Fisher Scientific Inc. (TMO) 5th Annual Evercore ISI HealthCONx Conference 2022 Transcript
- Thermo Fisher Scientific Inc. (NYSE:TMO ) 5th Annual Evercore ISI HealthCONx Conference 2022 November 29, 2022 10:30 AM ET Company Participants Marc Casper - Chairman, President and Chief Executive Officer Conference Call Participants Vijay Kumar - Evercore ISI Vijay Kumar Okay, thanks everyone for joining us this morning. It's a pleasure to have with us Thermo Fisher.
- 11/29/2022
|
Thermo Fisher (TMO) Up 9.8% Since Last Earnings Report: Can It Continue?
- Thermo Fisher (TMO) reported earnings 30 days ago. What's next for the stock?
- 11/25/2022
|
Thermo Fisher CEO: Covid vaccines, therapies will be needed well into the future
- Thermo Fisher Scientific CEO Marc Casper explained his outlook for the necessity of coronavirus vaccines and therapies as the country continues to battle the pandemic.
- 11/19/2022
|
3 Unstoppable Growth Stocks to Buy and Hold
- These businesses are built for the long run.
- 11/19/2022
|
Rockwell Automation CEO on Thermo Fisher Scientific, Kraft Heinz partnerships
- Rockwell Automation CEO Blake Moret broke down the industrial automation and information technology company's relationships with Thermo Fisher Scientific and Kraft Heinz.
- 11/19/2022
|
Final Trades: Volkswagen, Chevron, Thermo Fisher & more
- The "Halftime Report" traders give their top picks to watch for the second half.
- 11/19/2022
|
Electric vehicles less reliable because of newer technologies, Consumer Reports finds
- Consumer Reports surveyed owners of more than 300,000 vehicles to make predictions about the reliability of 2023 model year vehicles.
- 11/15/2022
|
Thermo Fisher (TMO) Q3 Earnings Top Estimates, Margins Down
- Robust demand for Thermo Fisher's (TMO) laboratory products and biopharma services buoys optimism. However, lower Life Sciences Solutions segment revenues in the third quarter disappoint.
- 10/26/2022
|
Thermo Fisher Scientific Inc. (TMO) Q3 2022 Earnings Call Transcript
- Thermo Fisher Scientific Inc. (NYSE:TMO ) Q3 2022 Earnings Conference Call October 26, 2022 8:30 AM ET Company Participants Rafael Tejada - Vice President, Investor Relations Marc Casper - Chairman, President and Chief Executive Officer Stephen Williamson - Senior Vice President and Chief Financial Officer Conference Call Participants Jack Meehan - Nephron Research Derik De Bruin - Bank of America Patrick Donnelly - Citi Vijay Kumar - Evercore ISI Dan Brennan - Cowen Rachel Vatnsdal - JPMorgan Dan Arias - Stifel Tejas Savant - Morgan Stanley Operator Good morning, ladies and gentlemen and welcome to the Thermo Fisher Scientific 2022 Third Quarter Conference Call. [Operator Instructions] I would like to introduce our moderator for the call, Mr.
- 10/26/2022
|
Thermo Fisher Scientific (TMO) Beats Q3 Earnings and Revenue Estimates
- Thermo Fisher (TMO) delivered earnings and revenue surprises of 6.28% and 8.30%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
- 10/26/2022
|
Buying These 3 Stocks Could Be the Smartest Move You Ever Make
- Look past all the noise and think about the bigger picture.
- 10/19/2022
|
Why Thermo Fisher (TMO) Could Beat Earnings Estimates Again
- Thermo Fisher (TMO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 10/18/2022
|
What's in Store for Thermo Fisher (TMO) in Q3 Earnings?
- In terms of performance in high-growth and emerging markets, in its flagship facility for cell culture media in Grand Island, NY, Thermo Fisher (TMO) completes capacity expansion.
- 10/17/2022
|
Thermo Fisher (TMO) Launches New TaqPath Panel in Europe
- This panel of Thermo Fisher (TMO), apart from detecting GI bacteria, also helps in identifying the root cause of an infection and administering the best suitable treatment fast.
- 10/11/2022
|
7 Value Stocks That Are Too Cheap to Ignore
- With the global markets seeming poised to suffer a significant downturn, investors should prepare for this possibility by targeting cheap value stocks to buy. According to Investopedia.com, value-based investments refer to securities that trade at a price lower than the fundamentals imply.
- 10/09/2022
|
Two-minute drill: MSFT, LHX & TMO
- Margaret Patel, Allspring Global Investments portfolio manager, joins ‘Closing Bell: Overtime' to discuss some of her favorite picks: Microsoft, L3Harris and Thermo Fisher.
- 10/05/2022
|
10 Stocks Completely Avoid The Looming October 'Jinx'
- October is infamous for "jinxing" investors with massive drops — the last thing anyone wants following September's fall. The post 10 Stocks Completely Avoid The Looming October 'Jinx' appeared first on Investor's Business Daily.
- 10/03/2022
|
2 Dividend Stocks That Have Doubled Their Payouts in 5 Years
- Despite making big increases to their dividend payments, these stocks still have low payout ratios.
- 09/28/2022
|
Own good companies, be diversified and know your time horizon, says Albion Financial's Jason Ware
- Jason Ware, partner and CIO at Albion Financial, joins 'Power Lunch' to discuss investing strategies for the current macro environment, highlighting how to look for quality, low-volatility, defensive stocks.
- 09/26/2022
|
Thermo Fisher: One Of The Best Dividend Stocks Money Can Buy
- In this article, I start by providing a theoretical foundation that explains why owning low-yielding stocks makes sense. Thermo Fisher is a low-yielding dividend growth stock with the ability to outperform the market with a low-volatility profile.
- 09/18/2022
|
Here's who could benefit from Biden's biotech initiative, according to Oppenheimer's Jared Holz
- Oppenheimer's Jared Holz on President Biden's cancer initiative and what it means for biotech in the U.S. With CNBC's Melissa Lee and the Fast Money traders, Tim Seymour, Courtney Garcia, Guy Adami and Karen Finerman.
- 09/12/2022
|
Thermo Fisher Scientific Inc. (TMO) Morgan Stanley 20th Annual Global Healthcare Conference (Transcript)
- Thermo Fisher Scientific Inc. (NYSE:TMO ) Morgan Stanley 20th Annual Global Healthcare Conference Call September 12, 2022 9:55 AM ET Company Participants Marc Casper - President & Chief Executive Officer Conference Call Participants Tejas Savant - Morgan Stanley Tejas Savant All right, guys. Good morning.
- 09/12/2022
|
Here is What to Know Beyond Why Thermo Fisher Scientific Inc. (TMO) is a Trending Stock
- Thermo Fisher (TMO) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
- 08/31/2022
|
Thermo Fisher: A High Growth Health Care Name
- Thermo Fisher Scientific Inc. ( TMO , Financial) is a leading life sciences, diagnostics and laboratory products company. The company has worked to become customers' go-to name for life science products and consumables.
- 08/30/2022
|
2 Ultra-Growth Stocks to Buy Hand Over Fist and Hold Forever
- You've probably never heard of them, but they're both winners.
- 08/27/2022
|
The 7 Safest Blue-Chip Dividend Stocks to Buy for the Rest of 2022
- The safest blue-chip dividend stocks can be pretty easy to sort out. Investing in them makes sense in turbulent times like those we are currently experiencing.
- 08/23/2022
|
Thermo Fisher (TMO) to Offer Wheat & Sesame Allergy Testing
- Thermo Fisher's (TMO) ImmunoCAP blood tests receive FDA approval for wheat and sesame allergy diagnosis.
- 08/22/2022
|
Thermo Fisher: Strong Foundation For Growth
- Thermo Fisher has a very attractive product mix and market distribution. Strong performance across pharma, biotech, industrial, and diagnostics segments will continue well into the future.
- 08/18/2022
|
Three Stock Lunch: T-Mobile U.S., Thermo Fisher and Howmet Aerospace
- Jeff Kilburg, Sanctuary Wealth CIO, joins 'Power Lunch' to discuss Kilburg's investing take on three stocks; T-Mobile U.S., Thermo Fisher and Howmet Aerospace.
- 08/18/2022
|
Here's Why You Should Retain Thermo Fisher (TMO) Stock Now
- Investors are optimistic about Thermo Fisher's (TMO) better-than-expected results and robust international performance.
- 08/16/2022
|
Is Trending Stock Thermo Fisher Scientific Inc. (TMO) a Buy Now?
- Thermo Fisher (TMO) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
- 08/16/2022
|
Jim Cramer says these 7 Covid-era winning stocks have staying power
- The "Mad Money" host offered investors a list of Covid-era winning stocks he says are continuing to perform well on Monday's episode of the show.
- 08/08/2022
|
These Are The Ten Biggest Companies With Over 90% Institutional Ownership
- Institutional investors are big investors that generally buy shares on behalf of their clients or members.
- 08/04/2022
|
Earnings Continue to Win
- The stock market typically grows bumpy in the late summer as the second-quarter earnings season winds down. The fact is I believe any dip in my fundamentally superior Accelerated Profits stocks is a good buying opportunity – and based on recent action, I'm not the only one.
- 08/04/2022
|
Thermo Fisher Scientific CEO on how headwinds from Covid lockdowns in China became tailwinds
- CNBC's Jim Cramer spoke with Thermo Fisher Scientific CEO Marc Casper on Wednesday's episode of "Mad Money."
- 08/03/2022
|
These eight health-care stocks can keep you invested in the market with less worry
- You're tempted to increase exposure to stocks because of the market's strength. But you're still gun shy because of the painful selloff.
- 08/02/2022
|
Thermo Fisher Scientific Inc. (TMO) CEO Marc Casper on Q2 2022 Results - Earnings Call Transcript
- Thermo Fisher Scientific Inc. (NYSE:TMO ) Q2 2022 Earnings Conference Call July 28, 2022 8:30 AM ET Company Participants Rafael Tejada - Vice President, Investor Relations Marc Casper - Chairman, President and Chief Executive Officer Stephen Williamson - Senior Vice President and Chief Financial Officer Conference Call Participants Jack Meehan - Nephron Research Patrick Donnelly - Citi Mike Ryskin - Bank of America Rachel Vatnsdal - JPMorgan Matt Sykes - Goldman Sachs Dan Arias - Stifel Puneet Souda - SVB Securities Tejas Savant - Morgan Stanley Operator Good morning, ladies and gentlemen. Welcome to the Thermo Fisher Scientific 2022 Second Quarter Conference Call.
- 07/28/2022
|
Thermo Fisher (TMO) Q2 Earnings Top Estimates, Margins Down
- The year-over-year decline in Thermo Fisher's (TMO) Life Science Solutions and Specialty Diagnostics segment revenues is disappointing.
- 07/28/2022
|
7 S&P 500 Stocks to Buy on the Dip
- S&P 500 stocks to buy on the dip is our topic today. Unrelenting inflation and the potential response from the Federal Reserve have been of particular concern to investors.
- 07/28/2022
|
Is a Surprise Coming for Thermo Fisher (TMO) This Earnings Season?
- Thermo Fisher (TMO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- 07/27/2022
|
Thermo Fisher: Life Science Juggernaut On The Path To $1 Trillion In Market Cap
- Thermo Fisher Scientific is an under-the-radar healthcare company that prints money. What does Thermo Fisher do? Science! Some examples – manufacturing of lab equipment, diagnostic tests, and vaccines. They have a fast-growing clinical research business as well.
- 07/26/2022
|
Thermo Fisher: Why Buying Its 0.2% Yield Makes Sense
- Thermo Fisher is the perfect dividend growth stock despite its 0.20% dividend yield, which seems like a dealbreaker. However, it has all characteristics to deliver outperforming long-term capital gains for its investors without exposing investors to high volatility.
- 07/24/2022
|
Here's Why You Should Retain Thermo Fisher (TMO) Stock Now
- Investors are optimistic about Thermo Fisher's (TMO) strong end market growth and noteworthy acquisitions.
- 07/13/2022
|
3 Gene Sequencing Stocks With Potential to Gain in 2H22
- Here we look at three stocks, PKI, TMO and TXG, with robust genome sequencing capabilities that investors can keep a watch on.
- 07/13/2022
|
3 Unstoppable Growth Stocks To Buy in 2022 and Beyond
- They're weathering the bear market better than many.
- 07/06/2022
|
Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, July 28, 2022
- WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the second quarter 2022 before the market opens on Thursday, July 28, 2022, and will hold a conference call on the same day at 8:30 a.m. EDT. During the call, the company will discuss its financial performance, as well as future expectations. To listen, call (844) 200-6205 within the U.S. or (929) 526-1599 outside the U.S. The
- 07/05/2022
|
Danaher And Thermo Fisher: Buy These High-Quality Compounders At A Fair Price
- Two healthcare giants - Danaher and Thermo Fisher - are finally trading at a fair price. Over the last decades, both companies shown a great track record of excellent operations.
- 06/17/2022
|
3 Growth Stocks That Raised Their Guidance This Year
- These companies are bullish on 2022.
- 06/14/2022
|
Thermo Fisher's (TMO) Autoimmune Disease Test Gets FDA Nod
- Thermo Fisher's (TMO) RNA Polymerase III and EliA Rib-P blood tests are intended to diagnose systemic sclerosis and systemic lupus erythematosus.
- 06/10/2022
|
Thermo Fisher (TMO) to Promote Mass Spectrometry Imaging
- Thermo Fisher's (TMO) new deal with TransMIT will advance the use of the AP-SMALDI5 AF ion source with Orbitrap MS technology for spatial multi-omics applications.
- 06/09/2022
|
Thermo Fisher (TMO) North America Sales Grow, Margin Woe Stays
- Thermo Fisher (TMO) witnesses core business strength across segments, end markets, and geographies.
- 06/01/2022
|
Best Health Care Stocks To Invest In 2022? 3 Names To Watch
- Here are 3 top health care stocks to watch in the stock market right now.
- 05/26/2022
|
Thermo Fisher (TMO) to Advance Precision Medicine in Qatar
- Thermo Fisher's (TMO) collaboration with Qatar Genome Program will utilize the power of genomics to enhance the standard of healthcare for the Qatari population.
- 05/24/2022
|
This Growth Stock Is Raising Guidance Despite Multiple Headwinds
- The company is coming off a strong quarter and expects that pattern to continue.
- 05/13/2022
|
Thermo Fisher Scientific to Present at BofA Securities 2022 Healthcare Conference
- WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present at the BofA Securities 2022 Healthcare Conference on Wednesday, May 11, 2022, at 12:20 p.m. (EDT). You can access the webcast of the presentation via the Investors section of our website, www.thermofisher.com. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in
- 05/06/2022
|
Thermo Fisher (TMO) End Markets Strong, Margin Under Pressure
- Thermo Fisher's (TMO) core business strength was broad-based across segments, end markets, and geographies.
- 05/05/2022
|
Thermo Fisher's Q1 Results Show Why It's a Safe Growth Stock to Own
- The company took on a big acquisition and still delivered strong, profitable numbers.
- 05/05/2022
|
Final Trades: Thermo Fisher, Union Pacific & more
- The "Halftime Report" traders give their top picks to watch for the second half.
- 04/29/2022
|
Thermo Fisher (TMO) Q1 Earnings Beat Estimates, Margins Down
- The robust year-over-year revenue growth across Thermo Fisher's (TMO) Analytical Instruments and the Laboratory Products and Biopharma Services segments appears promising.
- 04/28/2022
|
Thermo Fisher Scientific's (TMO) CEO Marc Casper on Q1 2022 Results - Earnings Call Transcript
- Thermo Fisher Scientific Inc. (NYSE:TMO ) Q1 2022 Earnings Conference Call April 28, 2022 8:30 AM ET Company Participants Rafael Tejada – Vice President, Investor Relations Marc Casper – Chairman, President, and Chief Executive Officer Stephen Williamson – Senior Vice President and Chief Financial Officer Conference Call Participants Jack Meehan – Nephron Research Patrick Donnelly – Citi Derik De Bruin – Bank of America Tejas Savant – Morgan Stanley Vijay Kumar – Evercore Puneet Souda – SVB Leerink Securities Dan Arias – Stifel Matt Sykes – Goldman Sachs Operator Good morning, ladies and gentlemen, and welcome to Thermo Fisher Scientific 2022 First Quarter Conference Call. My name is Nadia, and I'll be coordinating your call today.
- 04/28/2022
|
Thermo Fisher Stock Rises Sharply After a Guidance Boost
- The scientific instrument maker says it will be raising prices to offset inflationary pressures.
- 04/28/2022
|
Thermo Fisher Scientific Stock Jumps As Q1 Earnings Surpass Consensus
- Thermo Fisher Scientific Inc (NYSE: TMO) has posted Q1 revenue of $11.82 billion, beating the consensus of $10.63 billion. Organic revenue growth was 3%, acquisitions increased revenue by 18%, and currency translation decreased revenue by 2%.
- 04/28/2022
|
Thermo Fisher Scientific (TMO) Surpasses Q1 Earnings and Revenue Estimates
- Thermo Fisher (TMO) delivered earnings and revenue surprises of 17.50% and 11.17%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
- 04/28/2022
|
Medical Products Stocks' Earnings on Apr 28: TMO, BIO & More
- Medical Products companies' results are likely to reflect a rebound in the base business. Let's see how TMO, BIO, LH and RMD fare this time.
- 04/27/2022
|
Thermo Fisher Scientific: The Healthcare Growth Stock To Choose In A Recession
- Warning of an economic recession arrived for the first time since 2019. TMO demonstrated its robust growth over the past years and future potential to further expand.
- 04/12/2022
|
Here's Why You Should Retain Thermo Fisher (TMO) For Now
- Investors are optimistic about Thermo Fisher's (TMO) better-than-expected fourth-quarter results and impressive COVID-19 response-related revenues.
- 04/12/2022
|
3 Best Life Sciences Stocks to Buy Now
- Thinking about digging into immunization stocks? Let's look more broadly, into life sciences stocks.
- 04/08/2022
|
Thermo Fisher (TMO) Debuts Raman Spectroscopic Analyzer
- Thermo Fisher's (TMO) Ramina Process Analyzer allows users to conduct precise in situ Raman measurements in a simple manner with high accuracy.
- 04/07/2022
|
Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, April 28, 2022
- WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the first quarter 2022 before the market opens on Thursday, April 28, 2022, and will hold a conference call on the same day at 8:30 a.m. EST. During the call, the company will discuss its financial performance, as well as future expectations. To listen, call (844) 200-6205 within the U.S. or (929) 526-1599 outside the U.S. The
- 04/05/2022
|
A Trio of Stocks Growing Earnings Faster Than Sales
- Investors may want to consider the following stocks, in my view, since they are growing earnings faster than sales, which may indicate efficient operating activities as profit margins expand along with growth.
- 04/05/2022
|
7 Medical Device Stocks to Buy as Covid-19 Fears Fade
- With concerns about Covid-19 fading into the rearview mirror, the normalization of healthcare could benefit these medical device stocks. The post 7 Medical Device Stocks to Buy as Covid-19 Fears Fade appeared first on InvestorPlace.
- 04/05/2022
|
Drink Some TEA
- Drink Some TEA
- 03/31/2022
|
Thermo Fisher (TMO) Launches NGS Platform for Clinical Labs
- Thermo Fisher's (TMO) Ion Torrent Genexus Dx Integrated Sequencer makes next-generation sequencing accessible for all clinical laboratories.
- 03/30/2022
|
Here's Why You Should Hold on to Thermo Fisher (TMO) Stock Now
- Investors are optimistic about Thermo Fisher (TMO) on its progress with COVID-19-related products and services.
- 03/24/2022
|
3 Stocks to Focus on With MedTech M&A Scaling New Heights
- MedTech stocks like Owens & Minor (OMI), Thermo Fisher (TMO) and Medtronic (MDT) are prudent investment choices given their long-term growth potential with recent M&A deals.
- 03/24/2022
|
3 Stocks For New Investors to Build Their Portfolios Around
- These stalwarts can be pillars for your portfolio for decades.
- 03/23/2022
|
Thermo Fisher's (TMO) New Buyouts Aid, Cost Pressure Ails
- Thermo Fisher's (TMO) high degree of response to the pandemic has enabled it to accelerate its growth strategy, strengthen customer relationships, and bump up investments.
- 03/22/2022
|
3 Supercharged Dividend Stocks to Buy if There's a Stock Market Sell-Off
- They have the products that keep customers coming back again and again forever.
- 03/11/2022
|
Here's A Better Pick Over Corning Stock
- We believe that Thermo Fisher Scientific currently is an attractive pick over Corning stock, despite TMO's comparatively higher valuation. TMO stock trades at 5.2x trailing revenues, compared to 2.2x for GLW stock.
- 03/10/2022
|
Thermo Fisher Scientific Inc. (TMO) CEO Marc Casper on 42nd Annual Cowen Health Care Conference (Transcript)
- Thermo Fisher Scientific Inc. (TMO) CEO Marc Casper on 42nd Annual Cowen Health Care Conference (Transcript)
- 03/07/2022
|
IHI: A Standout Performer With Equally Strong Future Growth Prospects
- IHI: A Standout Performer With Equally Strong Future Growth Prospects
- 03/05/2022
|
Why Is Thermo Fisher (TMO) Down 6.8% Since Last Earnings Report?
- Thermo Fisher (TMO) reported earnings 30 days ago. What's next for the stock?
- 03/04/2022
|
Thermo Fisher (TMO) Extends Collaboration With Symphogen
- Thermo Fisher's (TMO) recent extension of collaboration with Symphogen is intended to support biopharmaceutical discovery and development.
- 03/04/2022
|
This Healthcare Company Is A Better Pick Over Abbott Stock
- We think that Thermo Fisher Scientific stock (NYSE: TMO) currently is a better pick compared to Abbott Labs stock (NYSE: ABT), with a similar market capitalization in the healthcare sector, despite its comparatively expensive valuation.
- 03/04/2022
|
Health Care Stocks to Watch as Test to Treat Plan Looks to Prevent Lockdowns
- President Joe Biden announced during his State of the Union address on Tuesday that individuals who test positive for Covid-19 at a pharmacy will soon be able to get free antiviral treatments immediately after. The cost will be funded by the federal government, which could result in a huge boost to the revenue of companies in the pharmaceutical, pharmacy and diagnostic industries over the coming year.
- 03/03/2022
|
Thermo Fisher Scientific: 14% Revenue Boost From PPD Acquisition
- We estimate the PPD acquisition to contribute 14% of the company's total revenues in 2022, as well as $25 mln in cost synergies.
- 02/28/2022
|
Thermo Fisher (TMO) Extends Collaboration With Moderna
- Thermo Fisher (TMO) continues to be a trusted partner of Moderna, bringing a wide range of products and services enabling Moderna to deliver innovative medicines at an extraordinary speed and scale.
- 02/28/2022
|
Thermo Fisher: Wrongful Accusation By Market
- As the pandemic winds down, the market anticipates losing the tailwind from Covid activities, and has punished the entire life science sector. Thermo Fisher was part of this sell-off.
- 02/27/2022
|
Thermo Fisher (TMO) COVID Test Sales Grow, FX Woes Persist
- Thermo Fisher's (TMO) strong pandemic response stance enables it to accelerate its growth strategy, and bump up investments, which encourages it to raise the 2022 core organic growth guidance.
- 02/25/2022
|
Expert opinion: ‘Thermo Fisher will get its mojo back'
- It's been a tough year so far for Thermo Fisher Scientific Inc (NYSE: TMO), with the stock down nearly 20%, but Jim Lebenthal recommends patience because TMO will get its “mojo” back. Lebenthal backs holding TMO through the sell-off Lebenthal sees the recent sell-off as a period of consolidation, a characteristic of the high-flying stocks.
- 02/23/2022
|
Moderna and Thermo Fisher enter long-term agreement on large-scale manufacturing of COVID vaccine
- Moderna Inc. MRNA, -0.53% and life-sciences company Thermo Fisher Scientific Inc. TMO, -1.35% said Wednesday they have entered a long-term agreement to collaborate on large-scale manufacturing of the former's COVID-19 vaccine dubbed Spikevax and other therapies based on its mRNA technology. In a joint statement, the companies said they have already been working together to support Moderna's pipeline with Thermo Fisher providing clinical research and contract manufacturing services, including aseptic fill-finish services and packaging of the COVID vaccine.
- 02/23/2022
|
Riding The Stock Waves: Update On The Medical Devices Sector
- Riding The Stock Waves: Update On The Medical Devices Sector
- 02/21/2022
|
Here's Why You Should Hold on to Thermo Fisher (TMO) Stock Now
- Investors are optimistic about Thermo Fisher's (TMO) better-than-expected fourth-quarter results and impressive COVID-19 response-related revenues.
- 02/15/2022
|
Analysts Think Thermo Fisher Will Continue Its Run
- Is there still money to be made in Thermo Fisher Scientific Inc. ( TMO , Financial) stock? Analysts think so.
- 02/07/2022
|
Watch Jim Cramer's full interview with Thermo Fisher CEO Marc Casper
- "Mad Money" host Jim Cramer interviewed Thermo Fisher CEO Marc Casper on Wednesday's episode of the show.
- 02/02/2022
|
Thermo Fisher Scientific tops Q4 2021 consensus estimates
- Thermo Fisher Scientific (NYSE: TMO) shares are up pre-market after the Q4 2021 results that topped consensus estimates and full-year results. The company posted GAAP diluted earnings per share of $4.17 while adjusted EPS was $6.54.
- 02/02/2022
|
Thermo Fisher (TMO) Q4 Earnings Beat Estimates, Margins Down
- Thermo Fisher's (TMO) Q4 earnings surpassed the Zacks Consensus Estimate with strength across the Analytical Instruments segment driving the top line.
- 02/02/2022
|
Thermo Fisher Scientific's (TMO) CEO Marc Casper on Q4 2021 Results - Earnings Call Transcript
- Thermo Fisher Scientific's (TMO) CEO Marc Casper on Q4 2021 Results - Earnings Call Transcript
- 02/02/2022
|
Thermo Fisher Scientific (TMO) Surpasses Q4 Earnings and Revenue Estimates
- Thermo Fisher (TMO) delivered earnings and revenue surprises of 25.29% and 18.56%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
- 02/02/2022
|
Thermo Fisher Q4 Earnings Beat Consensus, Clocks COVID-19 Revenue Of $2.45B
- Thermo Fisher Scientific Inc TMO has posted Q4 revenues of $10.70 billion, up 1% Y/Y, beating the consensus of $9.29 billion. Thousands of new traders are learning the ins and outs on how to find profitable trades every day with Benzinga Trading School.
- 02/02/2022
|
Thermo Fisher stock rallies after big earnings beat, boosted by nearly $2.5 billion in COVID-19 response revenue
- Shares of Thermo Fisher Scientific Inc. TMO, +2.24% rallied 2.5% in premarket trading Wednesday, after the analytic and diagnostic instruments company reported big fourth-quarter profit and revenue beats, boosted by nearly $2.5 billion in COVID-19 response revenue. Net income fell to $1.66 billion, or $4.17 a share, from $2.50 billion, or $6.24 a share, in the year-ago period.
- 02/02/2022
|
Medical Products Stock Earnings on Feb 2: BSX, TMO & More
- Medical Products companies' Q4 results are likely to reflect an increase in COVID-19 testing demand. Let's see how BSX, TMO, HOLX and MCK are poised ahead of their earnings releases.
- 02/01/2022
|
3 Companies Growing Revenue Per Share Fast
- The S&P 500 stocks saw their aggregate trailing 12-month real revenue per share increase at a compound annual growth rate of approximately 3.5% over the past five years. The benchmark index for the U.S. stock market closed at 4,431.85 on Friday, up nearly 93% over the past five years through Jan. 28.
- 01/31/2022
|
Why Thermo Fisher (TMO) Might Surprise This Earnings Season
- Thermo Fisher (TMO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- 01/31/2022
|
5 Corporate Giants Likely to Gain From Q4 Earnings Next Week
- Five corporate behemoths will report fourth-quarter 2021 earnings results next week. These are: TMO, FB, GOOGL, GILD and UPS.
- 01/28/2022
|
5 Top Health Care Stocks To Watch Before February 2022
- Should investors be paying more attention to these health care stocks?
- 01/27/2022
|
Thermo Fisher (TMO) Base Sales Rebound, Bioproduction in Focus
- Thermo Fisher (TMO) is currently expanding its bioproduction purification resin capacity, which is used in the mRNA manufacturing process.
- 01/27/2022
|
Thermo Fisher Scientific (TMO) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
- Thermo Fisher (TMO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 01/26/2022
|
Healthy Dividends: Thermo Fisher's Growth Fuels Capital Deployments
- Thermo Fisher Scientific is the world leader of life science products, analytical instruments, and diagnostic products. The company's growth trajectory is impressive considering its market cap is roughly $228B.
- 01/26/2022
|
Rise in COVID Tests to Boost Thermo Fisher (TMO) Q4 Earnings
- With the emergence of the Omicron variant through the Q4 months globally, Thermo Fisher's (TMO) Life-Science Solutions segment is likely to have registered strong top-line contributions.
- 01/25/2022
|
Here's Why You Should Retain Thermo Fisher (TMO) Stock for Now
- Investors are optimistic about Thermo Fisher's (TMO) strong end-market growth and focus on international regions.
- 01/13/2022
|
This Healthcare Company Is A Better Pick Over Honeywell Stock
- We think that Thermo Fisher Scientific stock currently is a better pick compared to Honeywell stock stock, despite it being the more expensive of the two, trading at 6.7x trailing revenues compared to 4.1x for Honeywell. Even if we were to look at the P/EBIT ratio, TMO stock appears to be.
- 01/13/2022
|
Thermo Fisher Scientific Inc. (TMO) CEO Marc Casper Presents at JPMorgan 40th Annual Healthcare Conference (Transcript)
- Thermo Fisher Scientific Inc. (TMO) CEO Marc Casper Presents at JPMorgan 40th Annual Healthcare Conference (Transcript)
- 01/11/2022
|
Will Thermo Fisher (TMO) Beat Estimates Again in Its Next Earnings Report?
- Thermo Fisher (TMO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 01/07/2022
|
Thermo Fisher (TMO) Completes Buyout of PeproTech for $1.85B
- Thermo Fisher's (TMO) recent acquisition will boost its capabilities to serve in the high-growth cell and gene therapy market.
- 01/07/2022
|
Thermo Fisher Scientific (TMO) Gains As Market Dips: What You Should Know
- Thermo Fisher Scientific (TMO) closed the most recent trading day at $620.40, moving +0.3% from the previous trading session.
- 01/06/2022
|
4 Stocks to Watch Out For as MedTech Rides on Buyout Frenzy
- Here are some MedTech stocks - Quidel (QDEL), Thermo Fisher (TMO), Baxter (BAX) and BD (BDX) - that have been quite active in the acquisition front and therefore worth investor attention.
- 01/06/2022
|
This Healthcare Company Is Likely To Offer Better Returns Over 3M Stock
- We think that Thermo Fisher Scientific stock currently is a better pick compared to 3M stock, despite Thermo Fisher Scientific trading at a more expensive valuation of 6.5x trailing revenues compared to 2.9x for 3M stock. Even if we were to look at P/EBIT ratio, TMO stock appears to be more.
- 01/05/2022
|
5 Unbeatable Dividend Growth Stocks for 2022
- Beat the market with dividend stocks like Toll Brothers (TOL), Microsoft (MSFT), Avery Dennison (AVY), J.B. Hunt (JBHT) and Thermo Fisher (TMO) in 2022.
- 01/04/2022
|
3 Diagnostics Stocks in Focus Amid the Omicron Outbreak
- Stocks like Thermo Fisher (TMO), QIAGEN (QGEN) and Quidel (QDEL) are expected to gain from increasing testing demand.
- 01/03/2022
|
Consistent Sales And Margin Growth Makes Thermo Fisher Scientific Stock Attractive
- We think that Thermo Fisher Scientific Inc. currently is a better pick compared to Qualcomm Inc.. Both companies have their current P/S multiples around 6x, while TMO's current P/EBIT stands marginally higher at 23x.
- 01/03/2022
|
Thermo Fisher Scientific (TMO) Gains As Market Dips: What You Should Know
- Thermo Fisher Scientific (TMO) closed the most recent trading day at $667.24, moving +0.27% from the previous trading session.
- 12/31/2021
|
Thermo Fisher (TMO) Hits a 52-Week High: What's Driving It?
- Strength in end markets and significant contribution from COVID-response related revenues are driving Thermo Fisher's (TMO) top line.
- 12/31/2021
|
Thermo Fisher Scientific to Present at the 2022 Goldman Healthcare CEOs Unscripted Conference
- WALTHAM, Mass. , Dec. 30, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N.
- 12/30/2021
|
Stocks This Week: Buy The NASDAQ ETFs And Hold Technology Stocks
- The NASDAQ is likely to be the leading index through the first week of January.
- 12/26/2021
|
Thermo Fisher (TMO) Releases New Update for Omicron Detection
- Thermo Fisher's (TMO) TaqMan SARS-CoV-2 Mutation Panel currently offers direct identification of the novel variant of concern.
- 12/24/2021
|
3 Promising Gene Sequencing Stocks to Watch Out For in 2022
- Here we look at three stocks, PKI, TMO and TXG, with robust genome sequencing capabilities that investors can keep a watch on.
- 12/22/2021
|
Is Thermo Fisher Scientific (TMO) Stock Outpacing Its Medical Peers This Year?
- Here is how Thermo Fisher Scientific (TMO) and West Pharmaceutical Services (WST) have performed compared to their sector so far this year.
- 12/20/2021
|
Thermo Fisher Scientific (TMO) Gains As Market Dips: What You Should Know
- In the latest trading session, Thermo Fisher Scientific (TMO) closed at $661.25, marking a +0.84% move from the previous day.
- 12/16/2021
|
3 Top Medical Instruments Stocks to Counter Industry Headwinds
- The Zacks Medical - Instruments industry is growing on COVID-support business gains. TMO, STE and ARAY are set to gain the most.
- 12/15/2021
|
Thermo Fisher (TMO) Gets FDA PMA for Oncomine Dx Target Test
- Thermo Fisher's (TMO) Oncomine Dx Target Test will allow clinicians to use FFPE tissue samples to spot patients in the United States who may benefit from the important new therapy.
- 12/13/2021
|
FDA Enlists Thermo Fisher, Google-Backed Verily COVID-19 Tests Likely To Be Affected By Omicron
- On Friday, the FDA published a list of molecular tests for COVID-19 that may be affected by mutations in the omicron variant of concern. The agency's list focuses on coronavirus tests impacted by S-gene dropout, an occurrence that is most commonly associated with Thermo Fisher Scientific Inc's (NYSE: TMO) TaqPath test kits.
- 12/07/2021
|
Thermo Fisher (TMO) Launches K-12 COVID-19 Test in Texas Schools
- Thermo Fisher's (TMO) ReadyCheckGo program will enable Texas schools to have the options for fast, reliable testing to identify and limit the spread of COVID-19 quickly.
- 12/06/2021
|
Chantico Global CEO invests in Thermo Fisher, Abbott Labs due to ongoing pandemic
- Chantico Global CEO Gina Sanchez joins the 'Halftime Report' to discuss where she's investing in the markets as the pandemic drags on.
- 12/03/2021
|
Is Thermo Fisher Scientific (TMO) Outperforming Other Medical Stocks This Year?
- Here is how Thermo Fisher Scientific (TMO) and West Pharmaceutical Services (WST) have performed compared to their sector so far this year.
- 12/02/2021
|
Virus and Fed Dampen Investors' Morale: 5 Low-Beta Stock Picks
- We have narrowed our search to five large-cap low-beta stocks that have provided higher returns than the market's benchmark the S&P 500 Index year to date. These are: TSCO, BG, EXPD, WSO and TMO.
- 12/01/2021
|
Thermo Fisher Says Its COVID-19 Tests Can Detect Omicron Variant
- Thermo Fisher Scientific Inc (NYSE: TMO) said that its COVID-19 diagnostic tests can accurately detect the new coronavirus variant Omicron. The Omicron variant has more than 30 mutations in the spike protein alone.
- 11/29/2021
|
Here's Why You Should Buy Thermo Fisher (TMO) Stock Now
- Investors are optimistic about Thermo Fisher (TMO) on strength in end markets and raised 2021 guidance.
- 11/23/2021
|
Thermo Fisher (TMO) New Facility to Advance Lab Products Supply
- Thermo Fisher's (TMO) new manufacturing facility will help the United States meet demand surges for vital laboratory products.
- 11/18/2021
|
Is Thermo Fisher Scientific (TMO) Stock Outpacing Its Medical Peers This Year?
- Is (TMO) Outperforming Other Medical Stocks This Year?
- 11/16/2021
|
Why Thermo Fischer Appears Undervalued
- The pandemic has been a tailwind for several sectors of the economy, including healthcare. One name that has especially benefited has been Thermo Fischer Scientific Inc. ( TMO , Financial).
- 11/14/2021
|
Thermo Fisher: Impressive Growth Story Just Got Better
- TMO has been growing at a solid pace (5 year average of 15.1%), as the health care industry and scientific research field just keeps getting bigger every day. Acquisition of contract research organization PPD will establish TMO as a leader in the rapidly growing clinical research industry and further fuel TMO's growth.
- 11/14/2021
|
7 Defensive Stocks To Add Portfolio Stability in the Fourth Quarter
- As we move through the fourth quarter, these top defensive stocks look great for portfolio stability and consistent returns long term. The post 7 Defensive Stocks To Add Portfolio Stability in the Fourth Quarter appeared first on InvestorPlace.
- 11/10/2021
|
Thermo Fisher (TMO) Hits Fresh High: Is There Still Room to Run?
- Thermo Fisher (TMO) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- 10/29/2021
|
Has Thermo Fisher Scientific (TMO) Outpaced Other Medical Stocks This Year?
- Is (TMO) Outperforming Other Medical Stocks This Year?
- 10/28/2021
|
Thermo Fisher CEO discusses long-term need for Covid testing and the company's China business
- Marc Casper, the chairman and CEO of Thermo Fisher Scientific, joined CNBC's Jim Cramer on Wednesday's episode of "Mad Money."
- 10/27/2021
|
Thermo Fisher Scientific Inc. (TMO) CEO Marc Casper on Q3 2021 Results - Earnings Call Transcript
- Thermo Fisher Scientific Inc. (TMO) CEO Marc Casper on Q3 2021 Results - Earnings Call Transcript
- 10/27/2021
|
Thermo Fisher (TMO) Beats on Q3 Earnings, Raises 2021 View
- Thermo Fisher (TMO) delivers a strong quarterly performance, leveraging on a significant rebound in its base business.
- 10/27/2021
|
Thermo Fisher's COVID-19 Response Revenue Accounts For 22% In Q3 Sales, Boosts FY21 Outlook
- Thermo Fisher Scientific Inc (NYSE: TMO) has posted Q3 revenues of $9.33 billion, up 9% Y/Y, beating the consensus of $8.39 billion. Organic revenue growth from the base business was 10%.
- 10/27/2021
|
Thermo Fisher Scientific (TMO) Q3 Earnings and Revenues Beat Estimates
- Thermo Fisher (TMO) delivered earnings and revenue surprises of 23.34% and 11.96%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
- 10/27/2021
|
Thermo Fisher Scientific: Q3 Earnings Insights
- Thermo Fisher Scientific (NYSE:TMO) reported its Q3 earnings results on Wednesday, October 27, 2021 at 06:00 AM. Here's what investors need to know about the announcement.
- 10/27/2021
|
Thermo Fisher lifts full-year forecast after third-quarter profit beat
- (Reuters) -Thermo Fisher Scientific Inc raised its full-year forecast and beat third-quarter profit estimates on strength in its life sciences unit, which makes raw materials for COVID-19 vaccines, and strong performance in its laboratory product segment.
- 10/27/2021
|
5 S&P 500 Stocks to Buy Ahead of Q3 Earnings This Week
- Five big S&P 500 companies (market capital > $45 billion) are slated to release third-quarter earnings results this week. These are: COF, DXCM, XOM, AFL and TMO.
- 10/26/2021
|
Thermo Fisher Scientific (TMO) Outpaces Stock Market Gains: What You Should Know
- Thermo Fisher Scientific (TMO) closed the most recent trading day at $608.41, moving +0.46% from the previous trading session.
- 10/21/2021
|
Wednesday Afternoon Analyst Upgrades and Downgrades: BHP, Ford, First Solar, Halliburton, SolarEdge, Thermo Fisher and More
- The earnings season rally continued into Wednesday with the Dow Jones industrial average hitting a record intraday high, taking out its previous high back in August.
- 10/20/2021
|
3 Dividend Stocks That Hiked Their Payouts by More Than 10% This Year
- And more rate hikes are likely in their future.
- 10/15/2021
|
Thermo Fisher (TMO) to Report Q3 Earnings: What's in Store?
- Thermo Fisher's (TMO) recent launches within Chromatography and Mass Spectrometry like Thermo Scientific Orbitrap IQ-X Tribrid Mass Spectrometer should have contributed to its Q3 top line.
- 10/13/2021
|
Is Thermo Fisher Scientific (TMO) Outperforming Other Medical Stocks This Year?
- Is (TMO) Outperforming Other Medical Stocks This Year?
- 10/12/2021
|
Thermo Fisher (TMO) Boosts COVID Testing With Wastewater Kit
- Thermo Fisher's (TMO) wastewater surveillance method is set to identify asymptomatic carriers on college campuses to monitor regional spread among communities.
- 10/12/2021
|
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 27, 2021
- WALTHAM, Mass., Oct. 11, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the third quarter 2021 before the market opens on Wednesday, October 27, 2021, and will hold a conference call on the same day at 8:30 a.m.
- 10/11/2021
|
Why Thermo Fisher (TMO) is Poised to Beat Earnings Estimates Again
- Thermo Fisher (TMO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 10/07/2021
|
Thermo Fisher Scientific Prices Offering of Euro-Denominated Senior Notes
- WALTHAM, Mass., Oct. 6, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO) ("Thermo Fisher") announced today that it has priced an offering of €5.25 billion aggregate principal amount (the "Offering") of the following euro-denominated notes, which will be issued by Thermo Fisher Scientific (Finance I) B.V.
- 10/06/2021
|
High Growth Dividend Stocks For October 2021
- I present 30 High Growth Dividend Stocks for consideration in October 2021. The watchlist from September 2021 had a -4.14% return last month beating both VIG and SPY.
- 10/06/2021
|
Thermo Fisher: Definitely Helped By COVID Testing But There Is More
- Thermo Fisher: Definitely Helped By COVID Testing But There Is More
- 10/06/2021
|
LGI: Interesting Closed-End Fund At A Wider Discount
- LGI: Interesting Closed-End Fund At A Wider Discount
- 10/05/2021
|
Henrietta Lacks Estate Sues Thermo Fisher Over Use Of Stolen Cells—Hints More Suits May Follow
- The lawsuit charges Thermo Fisher with “unjust enrichment” for profiting off of products made with HeLa cells.
- 10/04/2021
|
Thermo Fisher (TMO) Expands Biologics Network With New Facility
- Thermo Fisher's (TMO) Lengnau site will offer biopharma companies a pathway from development to large-scale production.
- 10/04/2021
|
Thermo Fisher Scientific Opens Biologics Manufacturing Site in Lengnau, Switzerland
- WALTHAM, Mass., Oct. 1, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced that it has assumed operational responsibility for a new biologics manufacturing site in Lengnau, Switzerland as part of its strategic partnership with CSL Limited announced last year.
- 10/01/2021
|
Thermo Fisher (TMO) Launches Kit for Safer Sample Collection
- Thermo Fisher (TMO) launches SpeciMAX Stabilized Saliva Collection Kit that can support global efforts toward SARS-CoV-2 research by ensuring safer saliva collection.
- 09/30/2021
|
Why Thermo Fisher Scientific (TMO) is a Top Momentum Stock for the Long-Term
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 09/29/2021
|
Thermo Fisher's (TMO) Delta Q IRMS to Back Sustainable Science
- Thermo Fisher (TMO) has introduced the new Delta Q IRMS under the IsoFootprint campaign to support sustainable science by eliminating carbon dioxide emission.
- 09/27/2021
|
Goldman Sachs added this lab equipment manufacturer to its ‘conviction buy list'
- Shares of Thermo Fisher Scientific Inc (NYSE: TMO) are up more than 30% on a year-to-date basis, but Goldman Sachs says “multiple growth drivers” will push the stock further up in 2022. Goldman Sachs sees 13% upside in Thermo Fisher In a note on Friday, Goldman Sachs' Matthew Sykes added Thermo Fisher to the firm's […] The post Goldman Sachs added this lab equipment manufacturer to its ‘conviction buy list' appeared first on Invezz.
- 09/24/2021
|
Thermo Fisher added to Goldman's 'Conviction Buy' list
- The "Halftime Report" traders debate Goldman's bullish call on Thermo Fisher.
- 09/24/2021
|
Quality Growth Stocks That Gurus Love
- It's rare for a stock to be able to achieve average annual returns above 20% for an entire decade. It's even more rare to do so while the company is consistently growing its top and bottom lines and maintaining a strong balance sheet.
- 09/23/2021
|
Final Trades: American Express, Live Nation, Thermo Fisher & more
- The "Halftime Report" traders give their top picks to watch for the second half. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/2NGeIvi » Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision » Subscribe to CNBC: https://cnb.cx/SubscribeCNBC » Subscribe to CNBC Classic: https://cnb.cx/SubscribeCNBCclassic Turn to CNBC TV for the latest stock market news and analysis.
- 09/23/2021
|
Thermo Fisher Scientific to Present at the JP Morgan 12th Annual U.S. All Stars Conference on September 22, 2021
- WALTHAM, Mass., Sept. 21, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N.
- 09/21/2021
|
Thermo Fisher (TMO) Introduces New Automated Enzyme Analyzers
- The two new Gallery Enzyme Master systems by Thermo Fisher (TMO) offer enhanced reliable enzyme analysis across several enterprises.
- 09/20/2021
|
Why Thermo Fisher Shares Are Trading Higher Today
- Thermo Fisher Scientific Inc (NYSE: TMO) is trading higher Friday after the company issued full-year 2022 financial guidance above analyst estimates. Thermo Fisher expects full-year 2022 earnings of $21.16 per share versus the estimate of $19.68 per share.
- 09/17/2021
|
Investor React Positively To Thermo Fisher's Annual Guidance
- Thermo Fisher Scientific Inc (NYSE: TMO) provided initial revenue and earnings guidance for 2022 while reiterating previously disclosed financial guidance for full-year 2021. Related: Thermo Fisher's Q2 Earnings Beat Expectations; Raises FY21 Outlook.
- 09/17/2021
|
Thermo Fisher's (TMO) Oncomine Dx Gets CDx Approval for EXKIVITY
- Thermo Fisher (TMO) gains FDA pre-market approval for Oncomine Dx as companion diagnostic for Takeda's EXKIVITY.
- 09/16/2021
|
Thermo Fisher's (TMO) Oncomine Dx Gets CDx Approval From MHLW
- Thermo Fisher's (TMO) Oncomine Dx Target Test has been approved by MHLW as a companion diagnostic for Eli Lilly and Company's selpercatinib.
- 09/15/2021
|
Here's Why Thermo Fisher Scientific (TMO) is a Strong Growth Stock
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 09/11/2021
|
Thermo Fisher Scientific to Host Virtual Investor Day
- WALTHAM, Mass., Sept. 9, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will host a virtual Investor Day on Friday, September 17, 2021, starting at 9:00 a.m.
- 09/09/2021
|
Thermo Fisher (TMO)-AstraZeneca to Co-Develop NGS-Based CDx
- Thermo Fisher's (TMO) new collaboration with AstraZeneca is intended to speed up development and introduction of targeted precision medicine therapies for patients.
- 09/06/2021
|
Thermo Fisher (TMO) Gains Government Contract for Pipette Tip
- Thermo Fisher (TMO) will co-invest with the U.S. government to build a new manufacturing center for pipette tips in North Carolina.
- 09/03/2021
|
Thermo Fisher Receives $192.5M Contract From US Govt For Pipette Tip Manufacturing
- Thermo Fisher Scientific Inc (NYSE: TMO) has announced a $192.5 million contract award from the U.S. Department of Defense (DoD). The contract covers the domestic production of pipette tips used within research and diagnostic labs to dispense precise amounts of liquid.
- 09/02/2021
|
Thermo Fisher's (TMO) Oncomine Dx Gets CDx Approval for TIBSOVO
- Thermo Fisher (TMO) receives FDA go-ahead for the Oncomine Dx Target Test as a CDx for Servier's ivosidenib tablets, TIBSOVO.
- 08/27/2021
|
Thermo Fisher Scientific (TMO) Gains As Market Dips: What You Should Know
- Thermo Fisher Scientific (TMO) closed at $552.77 in the latest trading session, marking a +0.86% move from the prior day.
- 08/26/2021
|
FDA Clears Thermo Fisher's Companion Diagnostic Test For Bile Duct Cancer Drug
- The FDA has granted pre-market approval to Thermo Fisher Scientific Inc's (NYSE: TMO) Oncomine Dx Target Test. The approval for the test comes as a companion diagnostic to identify patients with isocitrate dehydrogenase-1 (IDH1) mutated cholangiocarcinoma (CCA) who may be candidates for treatment with ivosidenib (Servier Pharmaceuticals' Tibsovo).
- 08/26/2021
|
Here's Why You Should Hold on to Thermo Fisher (TMO) for Now
- Investors are optimistic about Thermo Fisher (TMO) on robust segmental growth and raised 2021 guidance.
- 08/24/2021
|
This Unknown Biotech Has a Secret Weapon for Outsized Returns
- Bio-Rad's equity position in a German pharma company is an asset many investors may not realize.
- 08/21/2021
|
Why Dividend Investors Shouldn't Bother With Thermo Fisher
- You could be waiting a long time for the dividend to catch up to that of higher-paying stocks.
- 08/18/2021
|
Thermo Fisher (TMO) Hits a 52-Week High: What's Driving It?
- Strong performance by the four reported business segments is driving the top line for Thermo Fisher (TMO).
- 08/10/2021
|
Thermo Fisher Scientific Prices Offering of USD-Denominated Senior Notes
- WALTHAM, Mass., Aug. 9, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO) ("Thermo Fisher") announced today that it has priced an offering of $3.1 billion aggregate principal amount (the "Offering") of the following notes: $700 million aggregate principal amount of its 1.750% senior notes due 2028, at the issue price of 99.952% of their principal amount, $1.2 billion aggregate principal amount of its 2.000% senior notes due 2031, at the issue price of 98.827% of their principal amount, and $1.2 billion aggregate principal amount of its 2.800% senior notes due 2041, at the issue price of 99.508% of their principal amount.
- 08/09/2021
|
Thermo Fisher Scientific Announces Offering of USD-Denominated Senior Notes
- WALTHAM, Mass., Aug. 9, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO) ("Thermo Fisher") announced today that it intends to offer USD-denominated senior notes.
- 08/09/2021
|
3 Big Dividends, Paying Monthly, For Your Retirement Basea
- A monthly income stream provides a lot of flexibility for the income investor. Monthly dividends makes DCA work even better.
- 08/08/2021
|
Thermo Fisher Scientific (TMO) CEO, Marc Casper on Q2 2021 Results - Earnings Call Transcript
- Thermo Fisher Scientific (TMO) CEO, Marc Casper on Q2 2021 Results - Earnings Call Transcript
- 07/28/2021
|
Thermo Fisher Scientific (TMO) Tops Q2 Earnings and Revenue Estimates
- Thermo Fisher (TMO) delivered earnings and revenue surprises of 1.63% and 5.92%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
- 07/28/2021
|
Thermo Fisher Scientific: Q2 Earnings Insights
- Shares of Thermo Fisher Scientific (NYSE:TMO) remained unaffected after the company reported Q2 results. Quarterly Results Earnings per share rose 43.96% over the past year to $5.60, which beat the estimate of $5.49.
- 07/28/2021
|
Medical Device Stocks' Earnings on Jul 28: TMO, ALGN & More
- The sector's Q2 results are likely to reflect solid earnings and revenue growth on strong base business recovery.
- 07/27/2021
|
Thermo Fisher Scientific Commits to Achieve Net-Zero Carbon Emissions by 2050
- WALTHAM, Mass., July 27, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced its commitment to achieve net-zero carbon emissions by 2050.
- 07/27/2021
|
Thermo Fisher (TMO) to Report Q2 Earnings: What's in Store?
- With vaccine rollouts through Q2, Thermo Fisher's (TMO) Life-Science Solutions segment is likely to have registered top-line contributions from vaccine and therapy production supplies.
- 07/23/2021
|
Why Thermo Fisher (TMO) is Poised to Beat Earnings Estimates Again
- Thermo Fisher (TMO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 07/20/2021
|
Thermo Fisher (TMO) Advances Customer Research With New Launch
- Thermo Fisher's (TMO) new instrument enables high-resolution images of nanoparticles and beam-sensitive materials to be obtained from a commercially available desktop SEM.
- 07/19/2021
|
Alcoa, Comerica, Shell Midstream, Thermo Fisher and More Friday Afternoon Analyst Calls
- With the trading day past the halfway mark, the major averages were pulling back despite a strong start to the day.
- 07/16/2021
|
Thermo Fisher (TMO) to Meet Plasmid DNA Demand With New Facility
- Thermo Fisher's (TMO) new facility will manufacture materials that are essential for production of plasmid-based therapies and vaccines.
- 07/16/2021
|
Thermo Fisher Scientific Opens cGMP Plasmid DNA Manufacturing Facility in Carlsbad, California
- WALTHAM, Mass., July 15, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, has opened a new cGMP plasmid DNA manufacturing facility in Carlsbad, Calif.
- 07/15/2021
|
Thermo Fisher's (TMO) New Pact Drives Sustainable Lab Practices
- Thermo Fisher (TMO) expects to ACT label more than 1,200 additional SKUs to allow research, pharmaceutical and clinical laboratories to achieve their sustainability objectives.
- 07/14/2021
|
Thermo Fisher's (TMO) Rapid DNA Solution Gets FBI Approval
- Thermo Fisher's (TMO) RapidHIT ID DNA Booking System allows seamless integration of Rapid DNA into the law enforcement booking agency process.
- 07/12/2021
|
Thermo Fisher Scientific Declares Quarterly Dividend
- WALTHAM, Mass., July 8, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors has authorized a quarterly cash dividend of $0.26 per common share, payable on October 15, 2021, to shareholders of record as of September 15, 2021.
- 07/08/2021
|
Thermo Fisher (TMO) Introduces CoE in Clinical Metabolomics
- Thermo Fisher's (TMO) new research collaboration is aimed to provide the metabolomics community with advanced, best practices and standard operating procedures.
- 07/08/2021
|
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, July 28, 2021
- WALTHAM, Mass., July 7, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the second quarter 2021 before the market opens on Wednesday, July 28, 2021, and will hold a conference call on the same day at 8:30 a.m.
- 07/07/2021
|
Thermo Fisher Scientific Expands Corporate Leadership Team
- WALTHAM, Mass., July 7, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that Alan Sachs, who has served as chief scientific officer (CSO) since 2016, will assume the newly established role of chief medical officer (CMO) and will be succeeded by Karen E.
- 07/07/2021
|
Thermo Fisher Scientific and UC Davis Launch Center of Excellence in Clinical Metabolomics
- SAN JOSE, Calif. and DAVIS, Calif.
- 07/07/2021
|
Final Trades: Volkswagen, Chevron, Thermo Fisher & more
- The "Halftime Report" traders give their top picks to watch for the second half.
- 07/01/2021
|
Growing Demand For Laboratory Instruments Could Drive Thermo Fisher Scientific Stock Past $550
- Despite already rising almost 2x from its low in March 2020, at the current price of $505 per share, we believe Thermo Fisher Scientific stock has further upside potential. TMO stock has increased from $255 to $505 off its March 2020 bottom, a little more than the S&P which increased by around 90%.
- 06/30/2021
|
Here's How Much a $1000 Investment in Thermo Fisher Scientific Made 10 Years Ago Would Be Worth Today
- Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
- 06/23/2021
|
Thermo Fisher (TMO) Invites Applications for Oncomine Program
- Thermo Fisher (TMO) to review research proposals eligible for the Oncomine Clinical Research Grant program.
- 06/22/2021
|
Thermo Fisher's (TMO) New Launch Boosts Preclinical Development
- Thermo Fisher's (TMO) enhanced Quick to Clinic solution provides balance of speed and quality to accelerate and advance DNA to Investigational New Drug in as less as 13 months.
- 06/21/2021
|
5 Gurus Stocks With Predictable Businesses
- According to the GuruFocus All-in-One Screener, a Premium feature, the following companies have high business predictability ratings and wide margins of safety as of June 15.
- 06/15/2021
|
Final Trades: Cisco Systems, CVS, Thermo Fisher & more
- The "Halftime Report" traders give their top picks to watch for the second half.
- 06/15/2021
|
ADX: Deep Discount, Keeping Up With The S&P 500 YTD
- ADX: Deep Discount, Keeping Up With The S&P 500 YTD
- 06/11/2021
|
Thermo Fisher Scientific to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference on June 10, 2021
- WALTHAM, Mass., June 8, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N.
- 06/08/2021
|
Thermo Fisher (TMO) End Markets Rebound as COVID-19 Cases Drop
- In academic and government end markets, Thermo Fisher (TMO) grows on robust customer activity globally.
- 06/08/2021
|
4 Stocks to Watch in the Growing Nanotechnology Market
- Watch out for names like Onto Innovation (ONTO), DuPont de Nemours (DD), Thermo Fisher Scientific (TMO) and International Business Machines (IBM) as the nanotechnology market continues to grow.
- 06/08/2021
|
3 Medical Diagnostics Stocks in Focus on Long-Term Potential
- MedTech testing stocks like Quest Diagnostics Incorporated (DGX), Thermo Fisher Scientific, Inc. (TMO) and Laboratory Corporation of America Holdings (LH) are likely to survive post-pandemic.
- 06/07/2021
|
Final Trades: Wabtec, Thermo Fisher, Monster Beverage & more
- The "Halftime Report" traders give their top picks to watch for the second half.
- 06/02/2021
|
Moderna Taps Thermo Fisher to Help Scale Up COVID-19 Vaccine Production
- Moderna Inc (NASDAQ: MRNA) entered into an agreement with Thermo Fisher Scientific Inc (NYSE: TMO) for manufacturing and packaging its COVID-19 vaccine, as Moderna looks to scale up production. Thermo Fisher Scientific will provide fill-finish, labeling, and packaging services for Moderna's mRNA vaccine at Thermo Fisher's commercial manufacturing site in Greenville, North Carolina.
- 06/02/2021
|
3 Stocks Growing Free Cash Flow Fast
- If you are looking for investment opportunities among U.S.-listed equities, you may want to consider the stocks listed below, as they have seen their free cash flow (FCF) grow remarkably over recent years. As a result, these businesses should be equipped with enough flexibility to fund the development of projects and return cash to shareholders.
- 05/23/2021
|
Thermo Fisher (TMO) to Boost Cell Therapies With UCSF Deal
- Thermo Fisher's (TMO) collaboration with UCSF will enable end-to-end solution to accelerate cell therapy development and manufacturing with new facility.
- 05/20/2021
|
Thermo Fisher Scientific Declares Quarterly Dividend
- WALTHAM, Mass., May 19, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors has authorized a quarterly cash dividend of $0.26 per common share, payable on July 15, 2021, to shareholders of record as of June 15, 2021.
- 05/19/2021
|
Alphabet was the most widely held stock for the largest ESG funds. Here's what else they own
- The 20 largest ESG funds like tech. Google's parent company was the most commonly held stock across a majority of them.
- 05/18/2021
|
Thermo Fisher Scientific: Growth at a Reasonable Price
- With earnings growth averaging 16.2% per year over the past decade, Thermo Fisher Scientific Inc ( TMO , Financial) keeps its foot on the accelerator:
- 05/10/2021
|
With 1 Cure Behind It, This Breakthrough Biotech Takes Aim at a Bigger Market
- One company is setting itself apart in a crowded field.
- 05/07/2021
|
7 Cathie Wood Stocks That Are Worth Buying Now
- After a steep selloff in emerging growth companies, opportunities abound. Here are seven Cathie Wood stocks worth considering right now.
- 05/05/2021
|
Thermo Fisher Scientific Stock: A Bit Pricey But Can Still Perform Well Over The Long Run
- Thermo Fisher Scientific is a good-quality stock that is well-positioned to grow via M&A and organically in a growing industry. We outline the recent PPD, Inc. acquisition.
- 05/04/2021
|
Thermo Fisher Scientific Inc. (TMO) CEO Marc Casper on Q1 2021 Results - Earnings Call Transcript
- Thermo Fisher Scientific Inc. (TMO) CEO Marc Casper on Q1 2021 Results - Earnings Call Transcript
- 04/29/2021
|
Recap: Thermo Fisher Scientific Q1 Earnings
- Shares of Thermo Fisher Scientific (NYSE:TMO) fell 1.0% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 145.24% over the past year to $7.21, which beat the estimate of $6.65.
- 04/29/2021
|
Thermo Fisher Scientific Reports First Quarter 2021 Results
- WALTHAM, Mass., April 29, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the first quarter ended April 3, 2021.
- 04/29/2021
|
Healthcare ETFs on Radar As Q1 Earnings Unfold
- Further price movement of the healthcare ETFs depend on earnings releases from some big names like Pfizer (PFE), Merck (MRK), Thermo Fisher (TMO), AbbVie (ABBV), and Gilead Sciences (GILD) that dominate returns.
- 04/28/2021
|
Final Trades: XPO Logistics, Thermo Fisher, Bunge & more
- The "Halftime Report" traders give their top picks to watch for the second half.
- 04/26/2021
|
Thermo Fisher (TMO) to Report Q1 Earnings: WIll It Beat?
- Fewer hospital visits on growing new cases might have once again impacted the level of routine diagnostics testing activity for Thermo Fisher (TMO) in Q1.
- 04/26/2021
|
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
- Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
- 04/21/2021
|
PPD INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of PPD, Inc. - PPD
- NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of PPD, Inc. (NasdaqGS: PPD) to Thermo Fisher Scientific Inc. (NYSE: TMO). Under the terms of the proposed transaction, shareholders of PPD will receive only $47.50 in cash for each share of PPD that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or w
- 04/19/2021
|
Water ETFs: $111 Billion For Water Infrastructure
- Water ETFs: $111 Billion For Water Infrastructure
- 04/19/2021
|
Thermo Fisher (TMO) to Expand in Pharma Service With PPD Buyout
- Thermo Fisher's (TMO) $17.4-billion acquisition deal will offer the company meaningful cost and revenue synergies.
- 04/19/2021
|
MedTech M&A Scaling New Heights in 2021 on Rising Investor Wealth
- While smaller tuck-in acquisitions dominated the M&A space throughout 2020, 2021 is seeing a number of colossal deals.
- 04/16/2021
|
5 ETFs to Make the Most of Thermo Fisher Deal to Buy PPD
- Thermo Fisher Scientific (TMO) has agreed to buy the healthcare testing company PPD Inc. (PPD) for $17.4 billion in cash.
- 04/16/2021
|
Thermo Fisher Bets Big on Clinical Research With a $17.4 Billion Deal
- The scientific company is acquiring PPD, a contract research organization that also provides lab services.
- 04/15/2021
|
Thermo Fisher to buy PPD, in a cash deal valued at $17.4 billion including debt
- Shares of PPD Inc. rallied 7.3% in premarket trading Thursday, after Thermo Fisher Scientific Inc. confirmed an agreement to buy the pharmaceutical-testing company in a cash deal valued at $17.4 billion, including $3.5 billion in debt. Thermo Fisher shares gained 3.1% ahead of the open.
- 04/15/2021
|
Thermo Fisher nears deal to buy PPD for more than $15B
- Thermo Fisher is nearing a deal to buy PPD for more than $15 billion dollars, according to The Wall Street Journal. Contessa Brewer joins 'Closing Bell' to report.
- 04/14/2021
|
Thermo Fisher (TMO) Gets EUA for Amplitude/TaqPath COVID-19 Kit
- Thermo Fisher's (TMO) Amplitude Solution is likely to allow clinical and public health laboratories to process up to 8,000 samples in a single day with the help of minimum workforce.
- 04/14/2021
|
Thermo Fisher (TMO) Rides on End Markets as Pandemic Rages On
- In diagnostics and healthcare, Thermo Fisher (TMO) is experiencing high demand for COVID-19 testing and manages to record 200% growth.
- 04/13/2021
|
Thermo Fisher Scientific: The Covid-19 Testing Upside Continues
- Thermo Fisher Scientific (NYSE:TMO) is a well-known name in the pharmaceutical and biotech industries that has witnessed remarkable growth in 2020, leveraging on its capacity to extend support amidst the pandemic.
- 04/08/2021
|
Fears Of A Post-Pandemic Hangover Have Weighed On Thermo Fisher's Shares
- Fears Of A Post-Pandemic Hangover Have Weighed On Thermo Fisher's Shares
- 04/08/2021
|
Quality Dividend Growth Stock Watchlist For April 2021
- I present 30 Quality Dividend Growth Stocks for consideration in April 2021.
- 04/07/2021
|
Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, April 29, 2021
- WALTHAM, Mass., April 5, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the first quarter 2021 before the market opens on Thursday, April 29, 2021, and will hold a conference call on the same day at 8:30 a.m.
- 04/05/2021
|
First National Bank of Mount Dora, Trust Investmen Buys Thermo Fisher Scientific Inc, VMware.
- Investment company First National Bank of Mount Dora, Trust Investmen (Current Portfolio) buys Thermo Fisher Scientific Inc, VMware Inc, Fiserv Inc, Equinix Inc, Honeywell International Inc, sells Eastman Chemical Co, Valero Energy Corp, Texas Instruments Inc, Becton, Dickinson and Co, Citigroup Inc during the 3-months ended 2021Q1, according to the most recent filings of the investment company, First National Bank of Mount Dora, Trust Investmen. As of 2021Q1, First National Bank of Mount Dora, Trust Investmen owns 115 stocks with a total value of $287 million.
- 04/05/2021
|
3 Top Medical Instruments Stocks to Beat COVID-19 Resurgence Crisis
- 3 Top Medical Instruments Stocks to Beat COVID-19 Resurgence Crisis
- 03/30/2021
|
Thermo Fisher (TMO) Launches Surveillance Tool for COVID-19
- The latest launch of surveillance solution is an extremely timely development by Thermo Fisher (TMO) and is expected to witness fast market adoption.
- 03/29/2021
|
Thermo Fisher Scientific Launches In-Air SARS-CoV-2 Surveillance Solution
- WALTHAM, Mass., March 24, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced the launch of the Thermo Scientific AerosolSense Sampler, a new surveillance solution designed to deliver fast and highly reliable insight into the presence of in-air pathogens, including SARS-CoV-2.
- 03/24/2021
|
Accenture, NRG Energy, Thermo Fisher and More Thursday Afternoon Analyst Calls
- With the trading day about halfway over, the broad markets were mixed. The Nasdaq took something of a beating, with a loss of over 1% on the day.
- 03/18/2021
|
Friday Morning Market Highlights
|
7 Healthcare Stocks to Buy and Hold for the Long Term
- These steady, strong healthcare stocks are great picks for investors to buy and hold onto for at least the next five years. The post 7 Healthcare Stocks to Buy and Hold for the Long Term appeared first on InvestorPlace.
- 03/12/2021
|
Thermo Fisher Scientific (TMO) Gains But Lags Market: What You Should Know
- Thermo Fisher Scientific (TMO) closed at $446.87 in the latest trading session, marking a +1.23% move from the prior day.
- 03/05/2021
|
Forget Penny Stocks! Buy These High-Quality Stocks Instead
- Both of these giant stocks have outperformed the market over the past year by a mile.
- 03/04/2021
|
Thermo Fisher Scientific's (TMO) CEO Marc Casper Presents at Cowen 41st Annual Health Care Conference (Transcript)
- Thermo Fisher Scientific's (TMO) CEO Marc Casper Presents at Cowen 41st Annual Health Care Conference (Transcript)
- 03/03/2021
|
Thermo Fisher (TMO) Down 10.9% Since Last Earnings Report: Can It Rebound?
- Thermo Fisher (TMO) reported earnings 30 days ago. What's next for the stock?
- 03/03/2021
|
Could Thermo Fisher Scientific Stock Jump To Fresh Highs?
- Despite already rising 1.8x from its low in March 2020, at the current price of $460 per share, we believe Thermo Fisher Scientific stock has further upside potential. TMO stock has increased from $255 to $460 off the recent bottom, a little more than the S&P which increased by around 70% from.
- 03/03/2021
|
Thermo Fisher (TMO) Buys Mesa Biotech, Grows in Point of Care
- Mesa Biotech's point-of-care platform is likely to help Thermo Fisher (TMO) rapidly scale up manufacturing volume amid the pandemic.
- 03/01/2021
|
Coronavirus Mutations: Why The Battle Against Covid Is Just Beginning
- The battle against Covid-19 is about to get uglier. Coronavirus mutations threaten to undercut a year's worth of work upholding Covid stocks like Pfizer, Moderna and Regeneron Pharmaceuticals.
- 02/26/2021
|
Thermo Fisher (TMO) Rides on Pharma & Biotech Amid Pandemic
- Customers in Thermo Fisher's (TMO) industrial and applied end markets get affected by business disruptions due to the pandemic.
- 02/25/2021
|
WuXi Diagnostics Secures US$150 Million Series B Financing to Accelerate Market Penetration in Global Diagnostics Sector
- SHANGHAI, Feb. 23, 2021 /PRNewswire/ -- WuXi Diagnostic Investment (Cayman) Limited ("WuXi Diagnostics") announced that it has completed US$150 million in series B funding, joined by new investors including Thermo Fisher Scientific Inc. ("Thermo Fisher"), Shiyu Capital ("SHIYU"), ABC...
- 02/23/2021
|
Thermo Fisher Scientific Increases Quarterly Dividend
- WALTHAM, Mass., Feb. 23, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors has authorized a quarterly cash dividend of $0.26 per common share, payable on April 16, 2021, to shareholders of...
- 02/23/2021
|
ARKG: Precautionary Measures, But Transformational Objectives Remain Intact
- Cathie Wood and her team have shown investors that they have the capability to turn double-digit growth dreams into reality.
- 02/22/2021
|
Rockwell Automation CEO on Thermo Fisher Scientific, Kraft Heinz partnerships
- Rockwell Automation CEO Blake Moret broke down the industrial automation and information technology company's relationships with Thermo Fisher Scientific and Kraft Heinz.
- 02/04/2021
|
Thermo Fisher Scientific and JW Therapeutics Announce CAR-T Partnership in China
- WALTHAM, Mass., Feb. 3, 2021 /PRNewswire/ -- Thermo Fisher Scientific, the world leader in serving science, has signed an agreement with JW Therapeutics, a leading cell therapy company, to ensure non-exclusive commercial access to Thermo Fisher's Gibco CTS Dynabeads CD3/CD28. The...
- 02/03/2021
|
Thermo Fisher CEO: Covid vaccines, therapies will be needed well into the future
- Thermo Fisher Scientific CEO Marc Casper explained his outlook for the necessity of coronavirus vaccines and therapies as the country continues to battle the pandemic.
- 02/01/2021
|
Thermo Fisher Scientific Inc. (TMO) CEO Marc Casper on Q4 2020 Results - Earnings Call Transcript
- Thermo Fisher Scientific Inc. (TMO) CEO Marc Casper on Q4 2020 Results - Earnings Call Transcript
- 02/01/2021
|
Thermo Fisher (TMO) Q4 Earnings Beat on Growth in All Segments
- Thermo Fisher (TMO) records $3.2 billion of COVID-19 response revenues and accelerated growth in base business in Q4.
- 02/01/2021
|
Thermo Fisher Scientific (TMO) Q4 Earnings and Revenues Top Estimates
- Thermo Fisher (TMO) delivered earnings and revenue surprises of 3.35% and 2.67%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
- 02/01/2021
|
Thermo Fisher Scientific: Q4 Earnings Insights
- Shares of Thermo Fisher Scientific (NYSE:TMO) rose 0.7% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share were up 99.72% over the past year to $7.09, which beat the estimate of $6.56.
- 02/01/2021
|
Thermo Fisher tops Wall Street estimates in the fiscal fourth quarter
- Thermo Fisher Scientific Inc. (NYSE: TMO) reported its financial results for the fiscal fourth quarter on Monday that topped analysts' estimates for earnings and revenue. In related news, Vertex Pharmaceuticals is also scheduled to publish its Q4 earnings report on Monday after market close.
- 02/01/2021
|
Thermo Fisher's stock rallies after big earnings beat, as revenue jumps above $10 billion
- Shares of Thermo Fisher Scientific Inc. surged 2.2% in premarket trading Monday, after the health care diagnostics and therapies company reported a big earnings beat and revenue that soared to more than $10 billion for the first time. Net income rose to $2.50 billion, or $6.24 a share, from $1.00 billion, or $2.49 a share, in the year-ago period.
- 02/01/2021
|
Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2020 Results
- WALTHAM, Mass., Feb. 1, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the fourth quarter and full year ended December 31, 2020. Fourth Quarter and Full Year 2020 Highlights Fourth quarter...
- 02/01/2021
|
Healthcare Trends That Will Rule 2021
- Companies working in telehealth, at-home testing, and back-to-work solutions might just win the day -- and in fact, the whole year.
- 01/30/2021
|
Earnings Outlook for Thermo Fisher Scientific
- On Monday, February 01, Thermo Fisher Scientific (NYSE:TMO) will release its latest earnings report. Benzinga's outlook for Thermo Fisher Scientific is included in the following report.
- 01/29/2021
|
Should You Buy Thermo Fisher (TMO) Ahead of Earnings?
- Thermo Fisher (TMO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- 01/29/2021
|
Final Trades: Visa, Morgan Stanley, Thermo Fisher & more
- The "Halftime Report" traders give their top picks to watch for the second half.
- 01/26/2021
|
Thermo Fisher Scientific (TMO) Outpaces Stock Market Gains: What You Should Know
- In the latest trading session, Thermo Fisher Scientific (TMO) closed at $518.83, marking a +0.82% move from the previous day.
- 01/25/2021
|
Thermo Fisher (TMO) to Report Q4 Earnings: What's in Store?
- Thermo Fisher's (TMO) Life-Science Solutions and Specialty Diagnostics segments are expected to have contributed, banking on COVID-19-led growing healthcare needs.
- 01/25/2021
|
This Medical Device Maker Will Be Well Positioned Post COVID
- The pandemic is only a temporary setback for this diversified global manufacturer of medical devices.
- 01/21/2021
|
Thermo Fisher to acquire company with COVID-19 test
- Shares of Thermo Fisher Scientific Inc. are up 1.3% in premarket trading on Tuesday after the company said it will spend $450 million in cash to acquire Mesa Biotech Inc., a privately held medical testing company. It will also pay the company up to $100 million in additional milestone payments.
- 01/19/2021
|
Thermo Fisher (TMO) Expands in Viral Vector With Henogen Buyout
- The addition of Henogen's manufacturing capabilities in Europe complement Thermo Fisher's (TMO) four development and manufacturing sites in North America.
- 01/18/2021
|
Thermo Fisher Scientific (TMO) Gains As Market Dips: What You Should Know
- Thermo Fisher Scientific (TMO) closed at $503.14 in the latest trading session, marking a +1.25% move from the prior day.
- 01/15/2021
|
Thermo Fisher Scientific Acquires Viral Vector Manufacturing Business from Novasep
- WALTHAM, Mass. and LYON, France, Jan. 15, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc., (NYSE: TMO), the world leader in serving science, and Groupe Novasep SAS (Novasep), a leading supplier of services and technologies for the life sciences industry, today announced that Thermo...
- 01/15/2021
|
The 2021 Market Outlook And Some New Stock Picks - Ryan Detrick And Eddy Elfenbein Join Alpha Trader (Podcast Transcript)
- Welcome to Alpha Trader. We have a special double bill today in honor of wildcard weekend coming up on the show. Eddy Elfenbein of Crossing Wall Street giving us his top five new stocks for 2021. But first we are pleased to welcome back to the show, Ryan Detrick. He is Chief Market Strategist for LPL Financial. Ryan, welcome back to Alpha Trader.
- 01/14/2021
|
My Best Growth Stock for 2021
- The need for frequent and quick COVID-19 testing ensures that demand for its products won't slow down anytime soon.
- 01/14/2021
|
A Trio of Stock Picks for Growth-Oriented Investors
- The quarterly revenue and net income of the following companies have improved remarkably on a year over year basis, drawing the interest of growth-oriented investors.
- 01/12/2021
|
The 2021 Market Outlook And Some New Stock Picks - Ryan Detrick And Eddy Elfenbein Join Alpha Trader
- This week's Alpha Trader podcast features hosts Aaron Task and Stephen Alpher speaking with LPL Financial's Ryan Detrick and Eddy Elfenbein, editor of the Crossing Wall Street blog and portfolio manager of the AdvisorShares Focused Equity ETF (CWS).
- 01/12/2021
|
Thermo Fisher Scientific Inc. (TMO) Marc Casper Presents at 39th Annual JPMorgan Virtual Healthcare Conference (Transcript)
- Thermo Fisher Scientific Inc. (TMO) Marc Casper Presents at 39th Annual JPMorgan Virtual Healthcare Conference (Transcript)
- 01/11/2021
|
Why Tenet, CVS, Thermo Fisher And Sarepta Are Moving Today
- Tenet Healthcare (NYSE: THC) shares are trading higher after Jefferies upgraded the stock from Hold to Buy and raised its price target from $27 to $60. Tenet is a Dallas-based healthcare provider organization operating a collection of hospitals (65) and many outpatient facilities, including ambulatory surgery centers, urgent care centers, freestanding imaging centers, freestanding emergency rooms/micro-hospitals, and physician practices across the United States.
- 01/08/2021
|
Thermo Fisher Scientific (TMO) Outpaces Stock Market Gains: What You Should Know
- Thermo Fisher Scientific (TMO) closed at $485.21 in the latest trading session, marking a +1.57% move from the prior day.
- 01/06/2021
|
7 Coronavirus Stocks to Buy to Make Mass Vaccination Possible
- The Covid-19 vaccine rally isn't just limited to biotech firms. Here are the top coronavirus stocks that are making mass vaccination possible.
- 01/05/2021
|
Why the Earnings Surprise Streak Could Continue for Thermo Fisher (TMO)
- Thermo Fisher (TMO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 01/05/2021
|
Thermo Fisher Scientific (TMO) Outpaces Stock Market Gains: What You Should Know
- Thermo Fisher Scientific (TMO) closed at $465.78 in the latest trading session, marking a +0.88% move from the prior day.
- 12/31/2020
|
Thermo Fisher Scientific Acquires Programmable Dye Platform Pioneer Phitonex
- WALTHAM, Mass., Dec. 31, 2020 /PRNewswire/ -- Thermo Fisher Scientific, the world leader in serving science, today announced it has completed the acquisition of Phitonex, Inc., a Durham, North Carolina-based company that has pioneered a spectral dye platform for high-resolution biology...
- 12/31/2020
|
Thermo Fisher Scientific Announces Redemption of Senior Notes
- WALTHAM, Mass., Dec. 30, 2020 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that on December 31, 2020, it will give notice of its intention to redeem the following Senior Notes, representing an aggregate total principal...
- 12/30/2020
|
7 Nanotech Stocks To Buy With Huge Returns in Store
- Seven nanotech stocks to buy have the potential to reward investors as innovation in the sector accelerates. The post 7 Nanotech Stocks To Buy With Huge Returns in Store appeared first on InvestorPlace.
- 12/30/2020
|
Thermo Fisher Scientific (TMO) Stock Sinks As Market Gains: What You Should Know
- Thermo Fisher Scientific (TMO) closed the most recent trading day at $458.34, moving -1.47% from the previous trading session.
- 12/23/2020
|
5 Health Care Stocks Outperforming the Benchmark
- According to the GuruFocus All-in-One Screener, a Premium feature, the following guru-owned health care stocks have outperformed the S&P 500 Index over the past 12 months through Dec. 22.
- 12/22/2020
|
Thermo Fisher Scientific (TMO) Outpaces Stock Market Gains: What You Should Know
- In the latest trading session, Thermo Fisher Scientific (TMO) closed at $464.51, marking a +1.47% move from the previous day.
- 12/17/2020
|
Andreas Halvorsen's Top 5 Health Care Positions as of the 3rd Quarter
- According to current portfolio statistics, a Premium feature of GuruFocus, the top five health care positions in Andreas Halvorsen (Trades, Portfolio)'s equity portfolio as of the third quarter are Adaptive Biotechnologies Corp. (NASDAQ:ADPT), Centene Corp. (NYSE:CNC), BridgeBio Pharma Inc. (NASDAQ:BBIO), Boston Scientific Corp. (NYSE:BSX) and Thermo Fisher Scientific Inc. (NYSE:TMO). This week, Halvorsen revealed a slight reduction to his Adaptive Biotechnologies position according to GuruFocus Real-Time Picks, which is also a Premium feature.
- 12/17/2020
|
5 MedTech Stocks That Have Outperformed the Industry in 2020
- Here are a few MedTech stocks which continued to outperform their respective industries amid the pandemic and can turn out to be wise investment choices.
- 12/17/2020
|
Thermo Fisher Scientific: A Brave New World (Of Healthcare Growth)
- The company is perfectly placed to take advantage of newfound structural growth within the healthcare industry. Covid-19 has provided a strong tailwind to earnings in 2020 and this looks set to be repeated in 2021.
- 12/08/2020
|
Top Wall Street analysts back these stocks as market notches record highs
- TipRanks analyst ranking service pinpoints Wall Street's best-performing stocks, like Salesforce and Five Below
- 12/06/2020
|
2 Stocks to Buy With Multiple COVID-19 Vaccines in Sight
- The demand for cold storage and transportation could make these stocks scorching-hot buys.
- 12/04/2020
|
Top Growth Stocks For December
- Growth names have been at the forefront of this new COVID world, and have kept society not only afloat, but growing and transitioning to this new normal. Nobody knows exactly what the future will hold, but our AI algorithms have identified standout growth stocks via our rating system.
- 12/02/2020
|
Thermo Fisher Scientific Stock Is Rising With High Composite Rating
- The IBD SmartSelect Composite Rating for Thermo Fisher Scientific rose from 94 to 98 Tuesday. The post Thermo Fisher Scientific Stock Is Rising With High Composite Rating appeared first on Investor's Business Daily.
- 12/01/2020
|
Ultra-Cold Freezer Makers To Profit From Covid-19 Vaccine Rush
- Excited about the Covid-19 vaccines from Pfizer and Moderna? You'll be waiting a long time unless the vaccines can be shipped at 94 degrees below zero.
- 11/21/2020
|
Thermo Fisher Scientific Elects New Director to Board
- WALTHAM, Mass., Nov. 20, 2020 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced it has elected R. Alexandra "Alex" Keith to its board of directors. Ms. Keith's appointment brings the company's total number of board members to...
- 11/20/2020
|
COVID-19 Vaccine Rollout Challenges Put These Stocks in Focus
- With COVID-19 vaccine on the horizon, cold-chain storage stocks including TT, CARR and TMO; vial makers like GLW and WST; and logistic operators including UPS and FDX are set to hog the limelight.
- 11/20/2020
|
Top Growth Stocks For November
- Growth names have been at the forefront of this new COVID world, and have kept society not only afloat, but growing and transitioning to this new normal. Nobody knows exactly what the future will hold, but our AI algorithms have identified standout growth stocks via our rating system.
- 11/18/2020
|
Loftin: The future for healthcare continues to expand well beyond what we could imagine at this time
- Gerald Loftin, founder and principal at Proficient Wealth Counselors, discusses the potential for the healthcare industry well beyond the COVID pandemic, and which companies may present the best investment opportunities.
- 11/18/2020
|
Week In Review: RemeGen, A Yantai Biologics Company, Completes $515 Million Hong Kong IPO
- Innoforce, a Hangzhou company, formed a JV with Thermo Fisher Scientific to build a large biologics and steriles drug development and manufacturing facility in the Hangzhou Airport Economic Demonstration Area. Decheng Capital had good reason to be pleased when Merck paid $2.75 billion to acquire VelosBio, a company formed in 2017 to develop ROR1 ADCs for cancer.
- 11/15/2020
|
Daily Dividend Report: Union Pacific, Lam Research, Thermo Fisher Scientific, Microchip Technology, Fortive
- The Board of Directors of Union Pacific has declared a quarterly dividend of 97 cents per share on the company's common stock, payable December 30, 2020, to shareholders of record November 30, 2020. Union Pacific has paid dividends on its common stock for 121 consecutive years.
- 11/06/2020
|
Thermo Fisher Scientific and Innoforce Partner to Establish Biologics and Steriles Drug Manufacturing Facility in China
- WALTHAM, Mass. and SHANGHAI, Nov. 6, 2020 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, and Innoforce, a bioinnovation-enabling company, today announced they have signed a joint venture agreement to establish a new pharma services facility...
- 11/06/2020
|
Cramer on four coronavirus testing stocks worth owning
- "I bet the testing stocks have a lot more room to run," the "Mad Money" host said.
- 11/05/2020
|
Thermo Fisher Scientific Declares Quarterly Dividend and Authorizes $2.5 Billion of Share Repurchases
- WALTHAM, Mass., Nov. 5, 2020 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its board of directors declared a quarterly cash dividend of $0.22 per share. The dividend will be paid on January 15, 2021, to shareholders of...
- 11/05/2020
|
Thermo Fisher (TMO) Hits 52-Week High, Can the Run Continue?
- Thermo Fisher (TMO) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- 11/04/2020
|
Top Stocks To Buy Today As Markets Extend Gains Into Election Day
- Markets are set to continue yesterday's gains, as investors seem relieved that election day is finally here, and optimistic that we will know a winner sooner rather than later. For anxious investors looking to make sense of the markets, our AI has crunched the data to give you a set of Top Buys.
- 11/03/2020
|
7 5G Stocks to Buy for the Future of the Machine Internet
- The 2020s will see machine data become intelligence, intelligence become automation, and automation spread from factories to cities and your wrist. The post 7 5G Stocks to Buy for the Future of the Machine Internet appeared first on InvestorPlace.
- 11/03/2020
|
Strategist on which stocks could do well regardless of election outcome
- John Traynor, CIO at People's United Advisors, joins "Squawk Box" to discuss a couple of stocks that have the potential of doing well regardless of who wins the election.
- 11/02/2020
|
Thermo Fisher is More Than a Big Covid Winner
- Covid-19 brought $2 billion in revenue to Thermo Fisher during the third quarter, and the company will put it to work for the next decade of biotech drug discovery. The post Thermo Fisher is More Than a Big Covid Winner appeared first on InvestorPlace.
- 10/28/2020
|
